https://curecurrent.com/trials/a-clinical-trial-to-compare-efficacy-and-tolerability-of-faslodex-with-arimidex-in-patients-with-advanced-breast-cancer-36001https://curecurrent.com/trials/a-study-to-compare-administration-schedules-of-g-csf-filgrastim-for-primary-prophylaxis-of-febrile-neutropenia-36002https://curecurrent.com/trials/react-vascular-access-her2-negative-vascular-access-strategies-for-neo-adjuvant-breast-cancer-treatment-without-trastuzu-36003https://curecurrent.com/trials/randomized-trial-standard-of-care-vascular-access-strategies-for-neo-adjuvant-trastuzumab-based-breast-cancer-treatment-36004https://curecurrent.com/trials/vorinostat-in-treating-patients-with-stage-iv-breast-cancer-receiving-aromatase-inhibitor-therapy-36005https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-participants-with-hr-her2-advanced-breast-cancer-36006https://curecurrent.com/trials/phase-iiib-study-to-evaluate-the-safety-and-tolerability-of-herceptin-sc-with-perjeta-and-docetaxel-in-patients-with-her-36007https://curecurrent.com/trials/internet-based-cognitive-behavioral-therapy-for-breast-cancer-patients-with-climacteric-symptoms-36008https://curecurrent.com/trials/adaptation-of-a-knowledges-exchange-portal-between-kep-healers-and-patients-obstacles-and-sources-to-kep-use-for-breast-36009https://curecurrent.com/trials/study-of-mk-0752-in-combination-with-tamoxifen-or-letrozole-to-treat-early-stage-breast-cancer-36010https://curecurrent.com/trials/neoadjuvant-fdc-with-melatonin-or-metformin-for-locally-advanced-breast-cancer-36011https://curecurrent.com/trials/neoadjuvant-toremifene-with-melatonin-or-metformin-in-locally-advanced-breast-cancer-36012https://curecurrent.com/trials/health-benefits-of-expressive-writing-among-chinese-breast-cancer-survivors-36013https://curecurrent.com/trials/health-benefits-of-expressive-writing-study-one-36014https://curecurrent.com/trials/open-label-multi-center-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-cudc-907-in-subjects-with-advanc-36015https://curecurrent.com/trials/mindful-movement-in-women-receiving-adjuvant-or-neoadjuvant-therapy-for-breast-cancer-36016https://curecurrent.com/trials/patterns-of-breast-cancer-management-and-prognosis-of-breast-cancer-in-china-36017https://curecurrent.com/trials/pilot-study-of-curcumin-for-women-with-obesity-and-high-risk-for-breast-cancer-36018https://curecurrent.com/trials/collaborative-self-management-support-in-chronic-conditions-qualitative-study-36019https://curecurrent.com/trials/open-label-immunotherapy-trial-for-breast-cancer-36020https://curecurrent.com/trials/dietary-fish-and-omega-3-fatty-acids-for-breast-cancer-prevention-36021https://curecurrent.com/trials/acupuncture-for-chronic-lymphedema-36022https://curecurrent.com/trials/a-phase-i-clinical-study-for-evaluating-the-safety-of-masct-i-in-advanced-soild-tumor-36023https://curecurrent.com/trials/post-mastectomy-surveillance-to-detect-recurrence-in-breast-cancer-patients-36024https://curecurrent.com/trials/the-effect-of-taxane-chemotherapy-on-balance-in-breast-cancer-patients-36025https://curecurrent.com/trials/a-study-of-vinflunine-plus-gemcitabine-versus-paclitaxel-plus-gemcitabine-in-patients-with-advanced-breast-cancer-36026https://curecurrent.com/trials/rct-of-an-internet-based-cbt-program-for-sexuality-and-intimacy-problems-in-women-treated-for-breast-cancer-36027https://curecurrent.com/trials/mirna-and-relevant-biomarkers-of-bc-patients-undergoing-neoadjuvant-treatment-36028https://curecurrent.com/trials/neoadjuvant-nab-ptx-and-trastuzumab-for-er-negative-and-her2-positive-breast-cancer-36029https://curecurrent.com/trials/emotions-immunology-and-breast-cancer-36030https://curecurrent.com/trials/cosmetic-result-toxicity-in-post-mastectomy-immediate-reconstruction-expander-rt-36031https://curecurrent.com/trials/understanding-value-in-metastatic-breast-cancer-36032https://curecurrent.com/trials/doxorubicin-with-or-without-sildenafil-with-analysis-of-cardiac-markers-36033https://curecurrent.com/trials/investigating-the-preventative-ability-of-massage-therapy-on-paclitaxel-induced-peripheral-neuropathy-36034https://curecurrent.com/trials/lymphedema-progression-screening-using-mri-36035https://curecurrent.com/trials/study-of-immune-response-modifier-in-the-treatment-of-breast-ovarian-endometrial-and-cervical-cancers-36036https://curecurrent.com/trials/cavity-shaving-in-breast-conserving-surgery-for-breast-cancer-patients-36037https://curecurrent.com/trials/interventions-to-increase-screening-by-breast-cancer-survivors-and-their-high-risk-female-relatives-36038https://curecurrent.com/trials/a-study-of-sc-administration-of-trastuzumab-herceptin-by-sid-at-home-in-her2-positive-ebc-participants-36039https://curecurrent.com/trials/a-study-to-determine-the-value-of-18f-faza-pet-imaging-in-patients-with-breast-cancer-36040https://curecurrent.com/trials/study-of-insulin-like-growth-factor-igf-methotrexate-conjugate-in-the-treatment-of-advanced-tumors-expressing-igf-1r-36041https://curecurrent.com/trials/a-study-to-demonstrate-the-safety-and-preliminary-efficacy-of-18f-flt-in-patients-with-solid-tumours-or-lymphoma-36042https://curecurrent.com/trials/pilot-study-to-define-the-immune-response-following-cryoablation-of-invasive-breast-cancer-36043https://curecurrent.com/trials/conventional-care-versus-radioablation-stereotactic-body-radiotherapy-for-extracranial-oligometastases-36044https://curecurrent.com/trials/dose-dense-doxorubucin-and-cyclophosphamide-followed-by-eribulin-mesylate-for-the-adjuvant-treatment-of-early-stage-brea-36045https://curecurrent.com/trials/vaccination-of-high-risk-breast-cancer-patients-36046https://curecurrent.com/trials/cryotherapy-in-preventing-peripheral-neuropathy-and-nail-toxicity-in-patients-with-breast-cancer-who-are-receiving-pacli-36047https://curecurrent.com/trials/ican-symptoms-duke-nus-36048https://curecurrent.com/trials/fsrt-in-breast-cancer-patients-with-brain-metastases-36049https://curecurrent.com/trials/a-mhealth-behavioral-cancer-pain-protocol-for-medically-underserved-communities-36050https://curecurrent.com/trials/optibra-study-optimal-postoperative-bra-after-breastcancer-surgery-36051https://curecurrent.com/trials/deep-learning-algorithms-for-prediction-of-lymph-node-metastasis-and-prognosis-in-breast-cancer-mri-radiomics-rbc-01-36052https://curecurrent.com/trials/a-study-evaluating-megestrol-acetate-modulation-in-hormone-receptor-positive-advanced-breast-cancer-36053https://curecurrent.com/trials/selective-intraoperative-administration-of-local-anesthesia-in-breast-reconstruction-36054https://curecurrent.com/trials/sentinel-lymph-node-mapping-post-injection-site-pain-36055https://curecurrent.com/trials/anthracycline-free-taxane-based-chemotherapy-in-patients-with-her2-neu-negative-early-breast-cancer-36056https://curecurrent.com/trials/secondary-breast-reconstruction-with-a-flap-of-skin-from-the-back-36057https://curecurrent.com/trials/promotora-navigator-culturally-appropriate-patient-navigator-36058https://curecurrent.com/trials/survival-benefits-of-statins-in-breast-cancer-patients-36059https://curecurrent.com/trials/study-of-icrucumab-imc-18f1-or-ramucirumab-drug-product-dp-in-combination-with-capecitabine-or-capecitabine-on-previousl-36060https://curecurrent.com/trials/homeopathic-protocol-for-advanced-breast-cancer-36061https://curecurrent.com/trials/prospective-study-to-measure-the-impact-of-mammaprint-on-adjuvant-treatment-in-hormone-receptor-positive-her2-negative-b-36062https://curecurrent.com/trials/nutrition-related-biomarkers-in-predicting-breast-cancer-risk-in-women-36063https://curecurrent.com/trials/neoadjuvant-study-of-pyrotinib-in-patients-with-her2-positive-breast-cancer-36064https://curecurrent.com/trials/a-study-of-the-use-of-airxpanders-aeroform-in-patients-undergoing-post-mastectomy-radiation-therapy-36065https://curecurrent.com/trials/dasatinib-in-combination-with-weekly-paclitaxel-for-patients-with-metastatic-breast-carcinoma-ca-180-194-36066https://curecurrent.com/trials/effects-of-computer-assisted-cognitive-rehabilitation-programs-with-breast-cancer-survivors-36067https://curecurrent.com/trials/metronomic-treatment-with-daily-oral-vinorelbine-as-first-line-chemotherapy-in-patients-with-advanced-metastatic-hormone-36068https://curecurrent.com/trials/temperature-and-injury-in-radiotherapy-radiation-skin-injury-36069https://curecurrent.com/trials/a-trail-of-neoadjuvant-endostar-in-combination-with-chemotherapy-in-breast-cancer-36070https://curecurrent.com/trials/a-study-of-first-line-js001-and-nab-paclitaxel-versus-palcelbo-and-nab-paclitaxel-in-participants-with-advanced-recurren-36071https://curecurrent.com/trials/study-in-patients-with-primary-breast-diffuse-large-b-cell-lymphoma-36072https://curecurrent.com/trials/food-effect-study-of-d-0502-tablet-in-healthy-volunteers-36073https://curecurrent.com/trials/study-to-evaluate-the-safety-biodistribution-radiation-dosimetry-and-tumor-imaging-potential-of-131i-sgmib-anti-her2-vhh-36074https://curecurrent.com/trials/survey-of-health-preferences-in-cancer-patients-qaly-cancer-36075https://curecurrent.com/trials/sunitinib-malate-paclitaxel-doxorubicin-hydrochloride-and-cyclophosphamide-before-surgery-in-treating-patients-with-stag-36076https://curecurrent.com/trials/efficacy-and-safety-study-of-abp-980-compared-with-trastuzumab-in-women-with-her2-positive-early-breast-cancer-36077https://curecurrent.com/trials/gs-5829-in-combination-with-fulvestrant-or-exemestane-in-women-with-advanced-estrogen-receptor-positive-her2-negative-br-36078https://curecurrent.com/trials/investigation-of-cancer-cell-extravasation-through-mrna-analysis-of-organ-specific-endothelial-cells-and-microfluidics-36079https://curecurrent.com/trials/radiotherapy-versus-low-dose-tamoxifen-following-breast-conserving-surgery-for-low-risk-breast-ductal-carcinoma-in-situ-36080https://curecurrent.com/trials/comparison-of-the-sensitivity-and-specificity-of-acoustic-angiography-to-the-sensitivity-and-specificity-of-conventional-36081https://curecurrent.com/trials/a-clinical-trial-to-assess-the-safety-of-0-005-estriol-vaginal-gel-in-hormone-receptor-positive-postmenopausal-women-wit-36082https://curecurrent.com/trials/effects-of-mediterranean-diet-based-intervention-in-breast-cancer-patients-36083https://curecurrent.com/trials/tumor-breast-ratio-study-36084https://curecurrent.com/trials/effect-of-sukshma-vyayama-yoga-on-aromatase-inhibitor-induced-arthralgia-in-breast-cancer-survivors-36085https://curecurrent.com/trials/tc-avastin-icorg-08-10-v6-36086https://curecurrent.com/trials/inflammation-induced-cns-glutamate-during-breast-cancer-treatment-36087https://curecurrent.com/trials/clinical-trial-with-two-physical-therapy-protocols-after-breast-cancer-surgery-and-immediate-reconstruction-36088https://curecurrent.com/trials/hand-held-gamma-camera-in-the-snoll-procedure-36089https://curecurrent.com/trials/seinior-quality-of-life-and-breast-cancer-in-older-women-36090https://curecurrent.com/trials/bone-metastasis-and-surgery-in-breast-cancer-36091https://curecurrent.com/trials/correlation-of-solitary-dilated-duct-at-mammography-with-ultrasonography-and-anatomopathological-findings-36092https://curecurrent.com/trials/500mg-fulvestrant-versus-exemestane-in-mbc-36093https://curecurrent.com/trials/pilot-study-of-biomarkers-and-cardiac-mri-as-early-indicators-of-cardiac-exposure-following-breast-radiotherapy-36094https://curecurrent.com/trials/tki258-for-metastatic-inflammatory-breast-cancer-patients-36095https://curecurrent.com/trials/salivary-cortisol-as-stress-marker-in-newborns-subjected-to-double-weighing-with-physiological-body-weight-36096https://curecurrent.com/trials/vaginal-laser-therapy-in-breast-cancer-survivors-36097https://curecurrent.com/trials/a-phase-iii-study-of-nk105-in-patients-with-breast-cancer-36098https://curecurrent.com/trials/kn035-in-combination-with-trastuzumab-and-docetaxel-in-her2-positive-breast-cancer-36099https://curecurrent.com/trials/corellation-of-mutations-tils-and-age-in-breast-cancer-36100https://curecurrent.com/trials/dna-in-predicting-response-after-systemic-therapy-in-women-with-metastatic-breast-cancer-36101https://curecurrent.com/trials/real-time-optical-coherence-tomography-oct-of-human-tissue-36102https://curecurrent.com/trials/laser-therapy-for-the-prevention-of-radiodermatitis-in-breast-cancer-patients-36103https://curecurrent.com/trials/tactile-breast-imaging-sensor-for-tumor-malignancy-characterization-36104https://curecurrent.com/trials/improving-compliance-with-medical-testing-guidelines-36105https://curecurrent.com/trials/treatment-of-hand-and-foot-syndrome-with-traditional-chinese-medicine-formula-lc09-in-patients-who-are-receiving-capecit-36106https://curecurrent.com/trials/assessment-of-the-impact-of-rna-genomic-profile-on-treatment-decision-making-in-her2-equivocal-breast-cancer-patients-36107https://curecurrent.com/trials/patient-report-outcome-reconstruction-and-oncoplastic-cohort-36108https://curecurrent.com/trials/pyrotinib-plus-fulvestrant-in-patients-with-hr-her2-metastatic-breast-cancer-pyrotinib-fulvestrant-36109https://curecurrent.com/trials/multiplex-testing-for-evaluation-of-breast-cancer-risk-longitudinal-study-36110https://curecurrent.com/trials/neoadjuvant-database-36111https://curecurrent.com/trials/nintedanib-letrozole-in-postmenopausal-women-with-breast-cancer-clinical-trial-safety-and-pharmacodynamics-36112https://curecurrent.com/trials/the-effect-of-an-inter-disciplinary-program-including-mbsr-in-breast-cancer-survivors-with-chronic-neuropathic-pain-36113https://curecurrent.com/trials/me-344-in-early-her2-negative-breast-cancer-with-antiangiogenic-induced-mitochondrial-metabolism-36114https://curecurrent.com/trials/the-andromeda-study-predictive-value-of-combined-criteria-to-tailor-breast-cancer-screening-36115https://curecurrent.com/trials/adherence-to-aromatase-inhibitors-the-role-of-partners-36116https://curecurrent.com/trials/exercise-intervention-after-cancer-treatment-for-improving-health-in-stage-ii-iii-breast-cancer-survivors-36117https://curecurrent.com/trials/a-proof-of-concept-window-trial-of-the-immunological-effects-of-avelumab-and-aspirin-in-triple-negative-breast-cancer-36118https://curecurrent.com/trials/a-study-to-assess-the-feasibility-of-an-e-health-system-zemy-designed-to-manage-symptoms-in-participants-with-breast-can-36119https://curecurrent.com/trials/phase-i-study-of-mln8237-and-pazopanib-in-patients-with-solid-tumors-36120https://curecurrent.com/trials/a-safety-study-of-sgn-2ff-for-patients-with-advanced-solid-tumors-36121https://curecurrent.com/trials/comparison-of-nutrition-education-alone-or-with-acupuncture-for-weight-loss-in-breast-cancer-patients-post-chemotherapy-36122https://curecurrent.com/trials/hypofractionated-vs-conventional-fractionated-radiotherapy-after-breast-conserving-surgery-36123https://curecurrent.com/trials/an-open-label-study-of-postmenopausal-women-with-oestrogen-receptor-positive-locally-advanced-or-metastatic-breast-cance-36124https://curecurrent.com/trials/lux-breast-1-bibw-2992-afatinib-in-her2-positive-metastatic-breast-cancer-patients-after-one-prior-herceptin-treatment-36125https://curecurrent.com/trials/evaluation-of-the-short-message-service-effectiveness-in-the-screening-invitation-strategy-for-breast-cancer-usimapi-36126https://curecurrent.com/trials/a-pd-study-of-oral-eft508-in-subjects-with-advanced-tnbc-and-hcc-36127https://curecurrent.com/trials/lee011-for-patients-with-cdk4-6-pathway-activated-tumors-signature-36128https://curecurrent.com/trials/randomized-clinical-trial-comparing-rehabilitation-robotic-versus-conventional-after-breast-cancer-surgery-36129https://curecurrent.com/trials/computed-optical-margin-assessment-for-breast-cancer-surgery-phase-i-part-b-36130https://curecurrent.com/trials/end-of-life-treatment-preferences-of-latino-medicare-beneficiaries-with-cancer-36131https://curecurrent.com/trials/a-multi-institutional-registry-for-cyberknife-stereotactic-accelerated-partial-breast-irradiation-ck-sapbi-36132https://curecurrent.com/trials/a-home-based-study-to-enhance-activity-in-breast-cancer-survivors-36133https://curecurrent.com/trials/nintedanib-for-her2-negative-metastatic-inflammatory-breast-cancer-mibc-36134https://curecurrent.com/trials/comparative-study-for-the-degree-of-biological-changes-after-short-term-2-weeks-and-4-weeks-preoperative-endocrine-thera-36135https://curecurrent.com/trials/assessing-efficacy-of-axillary-web-syndrome-treatment-36136https://curecurrent.com/trials/using-clinicopathomic-markers-to-predict-neoadjuvant-chemotherapy-response-in-breast-cancer-36137https://curecurrent.com/trials/magnetic-resonance-imaging-in-women-recently-diagnosed-with-unilateral-breast-cancer-36138https://curecurrent.com/trials/open-label-study-of-safety-tolerability-and-pharmacokinetics-of-multiple-doses-of-bi-con-02-in-patients-with-her2-positi-36139https://curecurrent.com/trials/follow-up-study-of-people-treated-for-scoliosis-36140https://curecurrent.com/trials/development-of-a-response-signature-to-neoadjuvant-chemotherapy-for-breast-cancer-36141https://curecurrent.com/trials/study-of-prophylactic-octreotide-to-prevent-or-reduce-the-frequency-and-severity-of-diarrhoea-in-subjects-receiving-lapa-36142https://curecurrent.com/trials/experience-of-arab-american-women-with-breast-cancer-in-depth-interviews-36143https://curecurrent.com/trials/a-comparison-of-intra-operative-radiotherapy-boost-with-external-beam-radiotherapy-boost-in-early-breast-cancer-36144https://curecurrent.com/trials/sfx-01-in-the-treatment-and-evaluation-of-metastatic-breast-cancer-36145https://curecurrent.com/trials/study-to-evaluate-surgical-excision-margins-in-malignant-breast-lumpectomies-with-the-peak-plasmablade-36146https://curecurrent.com/trials/hypofractionated-versus-conventional-fractionation-radiotherapy-36147https://curecurrent.com/trials/mirs03-paravertebral-block-with-ropivacaine-before-breast-cancer-surgery-36148https://curecurrent.com/trials/long-term-anastrozole-versus-tamoxifen-treatment-effects-36149https://curecurrent.com/trials/a-clinical-trial-in-patients-with-breast-cancer-susceptibility-gene-brca-defective-tumours-36150https://curecurrent.com/trials/addressing-modifiable-breast-cancer-risk-factors-with-project-conect-36151https://curecurrent.com/trials/capecitabine-in-combination-with-aromatase-inhibitor-versus-aromatase-inhibitors-in-hormonal-receptor-positive-recurrent-36152https://curecurrent.com/trials/impact-of-breast-cancer-gene-status-on-survival-in-adjuvant-breast-cancer-imbassa-36153https://curecurrent.com/trials/tw-her2-positive-breast-cancer-productivity-utility-study-36154https://curecurrent.com/trials/smart-phone-health-coaching-intervention-to-promote-maintenance-of-exercise-in-breast-cancer-survivors-protocol-36155https://curecurrent.com/trials/preoperative-testing-of-the-anti-progesterone-mifepristone-in-early-stage-breast-cancer-36156https://curecurrent.com/trials/genetic-study-of-cyp2d6-enzyme-and-therapeutic-drug-monitoring-of-tamoxifen-36157https://curecurrent.com/trials/role-of-indocyanine-green-icg-for-detection-of-sentinel-nodes-in-breast-cancer-36158https://curecurrent.com/trials/pilot-study-on-energy-therapy-or-massage-to-reduce-fatigue-36159https://curecurrent.com/trials/nutraceuticals-versus-usual-care-in-the-prevention-or-reduction-of-cipn-in-patients-treated-with-docetaxel-as-neoadjuvan-36160https://curecurrent.com/trials/doxorubicin-and-cyclophosphamide-ac-followed-by-weekly-docetaxel-as-neoadjuvant-treatment-of-breast-cancer-patients-36161https://curecurrent.com/trials/s0702-osteonecrosis-of-the-jaw-in-patients-with-cancer-receiving-zoledronic-acid-for-bone-metastases-36162https://curecurrent.com/trials/exploring-the-link-between-cancer-genetics-and-ppsp-36163https://curecurrent.com/trials/18f-fes-pet-ct-s-additional-clinical-value-in-er-bc-36164https://curecurrent.com/trials/studying-tissue-samples-from-women-with-breast-cancer-who-were-treated-on-clinical-trial-ncctg-n9831-36165https://curecurrent.com/trials/the-study-of-molecular-risk-panels-70-gene-assay-in-chinese-breast-cancer-patients-36166https://curecurrent.com/trials/a-study-evaluating-trastuzumab-emtansine-plus-pertuzumab-compared-with-chemotherapy-plus-trastuzumab-and-pertuzumab-for-36167https://curecurrent.com/trials/studying-blood-and-dna-samples-from-patients-with-breast-cancer-treated-with-chemotherapy-with-or-without-trastuzumab-36168https://curecurrent.com/trials/purpose-project-reclaiming-life-purpose-after-breast-cancer-feasibility-study-36169https://curecurrent.com/trials/lapatinib-in-women-with-metastatic-breast-cancer-who-have-failed-prior-antihormone-therapy-36170https://curecurrent.com/trials/a-pilot-phase-ii-study-of-gamma-knife-radiosurgery-for-brain-metastases-using-3tesla-mri-and-rational-dose-selection-36171https://curecurrent.com/trials/coxsackie-virus-a21-administered-intravenously-iv-for-solid-tumour-cancers-psx-x04-36172https://curecurrent.com/trials/adjuvant-acupuncture-care-for-breast-cancer-patients-experiencing-side-effects-from-chemotherapy-36173https://curecurrent.com/trials/effect-of-tdcs-of-the-motor-cortex-on-chemotherapy-induced-nausia-and-vomiting-36174https://curecurrent.com/trials/a-continuation-study-using-sunitinib-malate-for-patients-leaving-treatment-on-a-previous-sunitinib-study-36175https://curecurrent.com/trials/investigation-of-three-approaches-to-address-fear-of-recurrence-among-breast-cancer-survivors-36176https://curecurrent.com/trials/surgimend-vs-strattice-in-direct-to-implant-breast-reconstruction-a-prospective-randomized-trial-36177https://curecurrent.com/trials/multi-peptide-vaccine-with-basilixumab-for-breast-cancer-36178https://curecurrent.com/trials/a-study-of-pyrotinib-plus-vinorelbine-in-comparison-with-treatment-of-physician-s-choice-in-participants-with-her2-posit-36179https://curecurrent.com/trials/preoperative-breast-magnetic-resonance-imaging-for-patients-undergoing-mammoplasty-36180https://curecurrent.com/trials/zinc-l-carnosine-prevents-dysphagia-in-breast-cancer-patients-undergoing-adjuvant-radiotherapy-36181https://curecurrent.com/trials/azd9496-first-time-in-patients-ascending-dose-study-36182https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-cdk4-6-inhibitor-shr6390-combined-with-pyrotinib-in-the-treatment-of-her2-p-36183https://curecurrent.com/trials/personalised-risk-based-breast-cancer-prevention-and-screening-36184https://curecurrent.com/trials/treatment-of-breast-cancer-related-lymphoedema-36185https://curecurrent.com/trials/clinical-value-of-next-generation-sequencing-in-endocrine-therapy-for-advanced-hormone-receptor-positive-her-2-negative-36186https://curecurrent.com/trials/study-of-apatinib-combined-with-oral-vinorelbine-in-metastatic-her2-negative-breast-cancer-36187https://curecurrent.com/trials/neoadjuvant-hormonal-therapy-compared-to-neoadjuvant-chemotherapy-in-stage-iiib-c-and-iv-breast-cancer-patients-36188https://curecurrent.com/trials/500mg-fulvestrant-versus-everolimus-plus-exemestane-in-mbc-patients-refractory-to-previous-ai-36189https://curecurrent.com/trials/post-operative-outcomes-of-low-thermal-dissection-vs-traditional-electrosurgery-36190https://curecurrent.com/trials/deferasirox-for-treating-patients-who-have-undergone-allogeneic-stem-cell-transplant-and-have-iron-overload-36191https://curecurrent.com/trials/a-phase-1-2-study-of-medi4276-in-adults-subjects-with-select-her2-expressing-advanced-solid-tumors-36192https://curecurrent.com/trials/effects-of-chemotherapy-on-intestinal-bacteria-in-patients-with-newly-diagnosed-breast-cancer-36193https://curecurrent.com/trials/exercise-program-for-early-breast-cancer-survivors-36194https://curecurrent.com/trials/t-cell-receptor-immunotherapy-targeting-mage-a3-for-patients-with-metastatic-cancer-who-are-hla-a-01-positive-36195https://curecurrent.com/trials/lux-breast-2-afatinib-in-her2-human-epidermal-growth-factor-receptor-treatment-failures-36196https://curecurrent.com/trials/magnetic-seed-localisation-for-nonpalpable-breast-lesions-36197https://curecurrent.com/trials/correlation-of-genomic-variation-in-enzymes-responsible-for-metabolism-of-capecitabine-with-drug-metabolism-36198https://curecurrent.com/trials/preoperative-relaxation-training-and-acupuncture-to-minimize-perioperative-symptoms-in-breast-cancer-patients-36199https://curecurrent.com/trials/an-open-label-dose-escalation-study-of-incb054329-in-patients-with-advanced-malignancies-36200https://curecurrent.com/trials/body-image-satisfaction-following-permanent-black-or-invisible-uv-ink-tattoos-36201https://curecurrent.com/trials/interest-of-intrathecal-chemotherapy-with-liposomal-cytarabine-depocyte-in-meningeal-metastasis-of-breast-cancer-36202https://curecurrent.com/trials/continued-her2-suppression-with-lapatinib-plus-trastuzumab-versus-trastuzumab-alone-36203https://curecurrent.com/trials/a-study-to-investigate-the-tolerability-of-subcutaneous-sc-trastuzumab-administration-in-participants-with-human-epiderm-36204https://curecurrent.com/trials/women-s-healthy-eating-and-living-study-36205https://curecurrent.com/trials/carboplatin-and-eribulin-mesylate-in-triple-negative-breast-cancer-patients-36206https://curecurrent.com/trials/predictors-of-adjuvant-endocrine-therapy-in-women-with-breast-cancer-36207https://curecurrent.com/trials/evaluation-of-the-adhesion-to-the-genepy-network-36208https://curecurrent.com/trials/evaluation-of-pertuzumab-trastuzumab-and-taxane-in-the-standard-treatment-of-metastatic-breast-cancer-36209https://curecurrent.com/trials/phase-ii-study-of-allo-lmi-vaccine-with-il-2-for-stable-metastatic-breast-ca-36210https://curecurrent.com/trials/nanoparticle-albumin-bound-rapamycin-in-treating-patients-with-advanced-cancer-with-mtor-mutations-36211https://curecurrent.com/trials/the-efficacy-of-sentimag-in-detection-of-sentinel-node-biopsy-36212https://curecurrent.com/trials/brief-behavioral-therapy-in-improving-sleep-disorders-in-patients-with-stage-i-iii-breast-cancer-undergoing-chemotherapy-36213https://curecurrent.com/trials/clinical-application-of-ctdna-in-early-screening-of-breast-cancer-36214https://curecurrent.com/trials/circulating-tumor-dna-as-marker-of-therapeutic-efficacy-in-breast-cancer-patients-36215https://curecurrent.com/trials/a-prospective-validation-cohort-study-of-a-prediction-system-on-nsln-metastasis-in-early-breast-cancer-36216https://curecurrent.com/trials/strength-and-range-of-motion-in-women-undergoing-surgery-for-breast-cancer-36217https://curecurrent.com/trials/mirna-profiling-of-breast-cancer-in-patients-undergoing-neoadjuvant-or-adjuvant-treatment-for-locally-advanced-inflammat-36218https://curecurrent.com/trials/effect-of-mindful-eating-on-weight-management-in-breast-cancer-survivors-36219https://curecurrent.com/trials/nueva-vida-intervention-for-latina-breast-cancer-survivors-and-caregivers-36220https://curecurrent.com/trials/diagnostic-power-comparison-between-vocs-and-ctcs-36221https://curecurrent.com/trials/mini-afterc-intervention-for-fear-of-cancer-recurrence-36222https://curecurrent.com/trials/safety-study-of-nivolumab-with-nab-paclitaxel-plus-or-minus-gemcitabine-in-pancreatic-cancer-nab-paclitaxel-carboplatin-36223https://curecurrent.com/trials/correlation-of-16-18f-fluoro-17-estradiol-pet-imaging-with-esr1-mutation-36224https://curecurrent.com/trials/radiotherapy-anastrazole-concomitant-evaluation-of-the-side-effects-36225https://curecurrent.com/trials/icg-and-blue-dye-guided-sentinel-lymph-node-biopsy-in-patients-underwent-neoadjuvant-therapy-36226https://curecurrent.com/trials/glutamine-for-the-prevention-of-radiation-toxicity-in-subjects-conserving-therapy-36227https://curecurrent.com/trials/a-study-of-pyrotinib-plus-vinorelbine-in-patients-with-brain-metastases-from-her2-positive-metastatic-breast-cancer-36228https://curecurrent.com/trials/the-value-of-geriatric-assessments-in-older-patients-with-breast-cancer-36229https://curecurrent.com/trials/comparative-study-of-neoadjuvant-chemotherapy-with-and-without-zometa-for-management-of-locally-advanced-breast-cancers-36230https://curecurrent.com/trials/technology-and-navigation-to-improve-survivorship-care-36231https://curecurrent.com/trials/gf-gs-01-comparing-conventional-axillary-dissection-versus-sentinel-node-resection-in-clinically-node-negative-operable-36232https://curecurrent.com/trials/cancer-symptom-data-from-multiple-treatment-centers-36233https://curecurrent.com/trials/study-of-hf10-in-patients-with-refractory-head-and-neck-cancer-or-solid-tumors-with-cutaneous-and-or-superficial-lesions-36234https://curecurrent.com/trials/frequency-and-presentations-of-chronic-pain-following-breast-cancer-surgery-an-observational-study-in-a-tertiary-care-ho-36235https://curecurrent.com/trials/paclitaxel-injection-albumin-bound-for-neoadjuvant-treatment-of-breast-cancer-36236https://curecurrent.com/trials/the-carole-cardiac-related-oncologic-late-effects-study-36237https://curecurrent.com/trials/ovarian-cancer-non-interventional-study-ovatar-36238https://curecurrent.com/trials/dose-finding-study-of-pf-05212384-with-paclitaxel-and-carboplatin-in-patients-with-advanced-solid-tumor-36239https://curecurrent.com/trials/metronomic-low-dose-cyclophosphamide-and-methotrexate-with-or-without-bevacizumab-in-treating-women-with-metastatic-brea-36240https://curecurrent.com/trials/telephone-counseling-mailed-materials-versus-internet-interventions-in-overweight-cancer-survivors-36241https://curecurrent.com/trials/entinostat-lapatinib-ditosylate-and-trastuzumab-in-treating-patients-with-locally-recurrent-or-distant-relapsed-metastat-36242https://curecurrent.com/trials/acupuncture-prevents-chemobrain-in-breast-cancer-patients-36243https://curecurrent.com/trials/evaluation-of-priming-before-in-vitro-maturation-for-fertility-preservation-in-breast-cancer-patients-36244https://curecurrent.com/trials/acupuncture-for-cipn-in-breast-cancer-patients-36245https://curecurrent.com/trials/a-study-of-pregnancy-and-pregnancy-outcomes-in-women-with-breast-cancer-treated-with-trastuzumab-pertuzumab-in-combinati-36246https://curecurrent.com/trials/extent-of-breast-cancer-and-the-role-of-pre-operative-sonography-and-mri-36247https://curecurrent.com/trials/impact-of-a-surgical-sealing-patch-on-lymphatic-drainage-after-alnd-for-breast-cancer-36248https://curecurrent.com/trials/stop-heart-disease-in-breast-cancer-survivors-trial-36249https://curecurrent.com/trials/comparative-effectiveness-of-sentinel-lymph-node-biopsy-for-ductal-carcinoma-in-situ-36250https://curecurrent.com/trials/fulvestrant-with-or-without-azd6244-in-treating-patients-with-advanced-breast-cancer-that-progressed-after-aromatase-inh-36251https://curecurrent.com/trials/neoadjuvant-study-of-pyrotinib-and-trastuzumab-plus-vinorelbine-in-trastuzumab-refractory-her2-positive-breast-cancer-36252https://curecurrent.com/trials/adjuvant-treatment-recommendation-and-oncotype-dx-in-early-breast-cancer-36253https://curecurrent.com/trials/metronomic-therapy-in-metastatic-breast-cancer-36254https://curecurrent.com/trials/efficacy-of-cancer-support-programs-a-social-comparison-theory-analysis-36255https://curecurrent.com/trials/trastuzumab-and-letrozole-in-treating-postmenopausal-women-with-progressive-advanced-breast-cancer-36256https://curecurrent.com/trials/f511-cream-in-preventing-palmar-plantar-erythrodysesthesia-in-patients-receiving-doxorubicin-hydrochloride-liposome-for-36257https://curecurrent.com/trials/e-mosaic-electronic-tool-to-monitor-symptoms-36258https://curecurrent.com/trials/dynamic-monitoring-of-her2-and-ctdna-specific-mutations-in-patients-with-recurrent-or-metastatic-breast-cancer-by-digita-36259https://curecurrent.com/trials/cardiac-safety-and-efficacy-for-early-stage-breast-cancer-patients-treated-with-pegylated-liposomal-doxorubicin-pld-36260https://curecurrent.com/trials/study-of-st266-versus-saline-in-treating-skin-irritation-from-radiation-36261https://curecurrent.com/trials/effects-of-adjuvant-endocrine-therapy-with-aromatase-inhibitors-on-the-postoperative-lipid-levels-in-postmenopausal-brea-36262https://curecurrent.com/trials/breast-cancer-diet-intervention-study-36263https://curecurrent.com/trials/a-randomized-clinical-trial-36264https://curecurrent.com/trials/assessment-of-muscle-strength-and-volume-changes-in-patients-with-breast-cancer-related-lymphedema-36265https://curecurrent.com/trials/erector-spinae-plane-block-versus-serratus-plane-block-for-breast-surgery-36266https://curecurrent.com/trials/retroprospective-real-life-observatory-of-eribulin-36267https://curecurrent.com/trials/a-sleep-intervention-to-improve-outcomes-among-women-at-high-risk-of-breast-cancer-36268https://curecurrent.com/trials/estrogen-receptor-expression-in-breast-cancer-assessed-with-positron-emission-mammography-36269https://curecurrent.com/trials/safety-study-of-enzalutamide-mdv3100-in-patients-with-incurable-breast-cancer-36270https://curecurrent.com/trials/study-to-determine-the-utility-of-fes-pet-in-the-prediction-of-response-to-fulvestrant-in-women-with-estrogen-positive-m-36271https://curecurrent.com/trials/enalapril-maleate-and-doxorubicin-hydrochloride-in-treating-women-with-breast-cancer-36272https://curecurrent.com/trials/community-hospital-identification-of-high-cv-risk-patients-during-cancer-treatment-36273https://curecurrent.com/trials/topical-application-of-sulforaphane-containing-broccoli-sprout-extracts-on-radiation-dermatitis-36274https://curecurrent.com/trials/entinostat-in-chinese-postmenopausal-women-patients-with-locally-recurrent-or-metastatic-breast-cancer-36275https://curecurrent.com/trials/study-to-assess-breast-sensation-before-and-after-breast-cancer-treatment-36276https://curecurrent.com/trials/feasibility-of-preoperative-tattooing-of-percutaneously-biopsied-axillary-lymph-node-a-quasi-experimental-pilot-study-36277https://curecurrent.com/trials/lapatinib-in-combination-with-oral-vinorelbine-for-metastatic-breast-cancer-36278https://curecurrent.com/trials/tailored-neoadjuvant-chemotherapy-for-stage-ii-iii-breast-cancer-with-tumor-size-more-than-2-cm-36279https://curecurrent.com/trials/health-status-of-women-with-breast-cancer-36280https://curecurrent.com/trials/a-study-of-ispinesib-in-metastatic-breast-cancer-36281https://curecurrent.com/trials/nurse-amie-a-tablet-based-supportive-care-platform-in-metastatic-breast-cancer-36282https://curecurrent.com/trials/phase-2b-study-of-taxol-plus-sorafenib-or-placebo-in-patients-with-advanced-breast-cancer-36283https://curecurrent.com/trials/bioavailability-study-of-sparc1210-and-reference1210-in-subjects-with-metastatic-breast-cancer-36284https://curecurrent.com/trials/evaluation-of-a-3d-functional-metabolic-imaging-and-risk-assessment-system-for-classifying-women-at-high-risk-of-breast-36285https://curecurrent.com/trials/pharmacokinetic-study-of-sparc1613-and-reference1613-in-subjects-with-locally-recurrent-or-metastatic-breast-cancer-36286https://curecurrent.com/trials/intraoperative-molecular-diagnosis-of-sentinel-lymph-node-in-breast-cancer-patients-36287https://curecurrent.com/trials/a-evaluation-of-3d-functional-mira-system-in-women-with-mammographically-dense-breasts-36288https://curecurrent.com/trials/breast-mri-screening-in-women-treated-with-mediastinal-irradiation-for-hodgkin-s-disease-36289https://curecurrent.com/trials/phase-iii-study-of-vinflunine-plus-capecitabine-versus-capecitabine-alone-in-patients-with-advanced-breast-cancer-36290https://curecurrent.com/trials/analysis-of-circulating-epithelial-tumor-cells-in-peripheral-blood-in-patients-with-primary-non-metastatic-breast-cancer-36291https://curecurrent.com/trials/cardiac-toxicity-in-medical-treatment-of-breast-cancer-36292https://curecurrent.com/trials/intellectual-impairment-in-women-with-breast-cancer-36293https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-supine-mri-images-in-breast-conserving-surgery-36294https://curecurrent.com/trials/erlotinib-in-treating-women-undergoing-surgery-for-stage-i-stage-ii-or-stage-iii-breast-cancer-36295https://curecurrent.com/trials/combined-use-of-apatinib-mesylate-and-vinorelbine-versus-single-use-of-vinorelbine-in-triple-negative-breast-cancer-36296https://curecurrent.com/trials/a-study-to-evaluate-the-accuracy-of-a-breast-cancer-locator-bcl-in-patients-with-palpable-cancers-36297https://curecurrent.com/trials/bioprosthetic-mesh-to-expand-the-lower-pole-in-tissue-expander-reconstruction-36298https://curecurrent.com/trials/phase-i-study-of-the-combination-of-mln9708-and-fulvestrant-36299https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-cyclosporine-a-p-glycoprotein-breast-cancer-resistance-protein-and-organic-anion-trans-36300https://curecurrent.com/trials/a-study-of-pf-06647263-in-patients-with-advanced-solid-tumors-36301https://curecurrent.com/trials/trial-of-endocrine-against-locoregional-therapy-first-in-postmenopausal-women-with-early-breast-cancer-36302https://curecurrent.com/trials/intraoperative-radiation-therapy-in-early-stage-breast-cancer-36303https://curecurrent.com/trials/mri-and-cardio-pulmonary-exercise-testing-in-evaluating-exercise-intolerance-in-patients-with-stage-i-iii-breast-cancer-36304https://curecurrent.com/trials/effect-of-pembrolizumab-and-cisplatin-on-metastatic-locally-recurrent-or-inoperable-triple-negative-breast-cancer-36305https://curecurrent.com/trials/discomfort-assessment-of-senographe-pristina-patient-assisted-versus-standard-compression-mode-and-quality-assessment-of-36306https://curecurrent.com/trials/artificial-intelligence-vs-physicians-for-breast-cancer-patients-information-36307https://curecurrent.com/trials/18f-naf-pet-imaging-for-bone-scintigraphy-36308https://curecurrent.com/trials/cyclophosphamide-and-vaccine-therapy-with-or-without-trastuzumab-in-treating-patients-with-metastatic-breast-cancer-36309https://curecurrent.com/trials/breast-cancer-treatment-based-on-organ-like-culture-36310https://curecurrent.com/trials/calcitriol-physical-activity-and-bone-health-in-cancer-survivors-36311https://curecurrent.com/trials/impact-of-intensive-follow-up-for-bone-metastasis-on-characteristics-and-prognosis-of-chinese-breast-cancer-patients-36312https://curecurrent.com/trials/dti-diffusion-findings-in-breast-mri-screening-and-diagnostic-36313https://curecurrent.com/trials/pyrotinib-combined-with-capecitabine-metronomic-therapy-in-her2-postitive-advanced-breast-cancer-36314https://curecurrent.com/trials/a-pharmacodynamic-study-of-sirolimus-and-metformin-in-patients-with-advanced-solid-tumors-36315https://curecurrent.com/trials/phase-ii-clinical-study-of-pyrotinib-combined-with-etoposide-to-treat-her2-positive-advanced-breast-cancer-36316https://curecurrent.com/trials/assessing-the-response-rate-of-neo-adjuvant-paclitaxel-taxol-in-nigerian-women-with-breast-cancer-36317https://curecurrent.com/trials/maximum-tolerated-dose-safety-and-pharmacologic-study-of-trf-in-women-with-breast-cancer-36318https://curecurrent.com/trials/conformal-high-dose-intensity-modulated-radiation-therapy-for-disease-to-thoracic-and-lumbar-spine-36319https://curecurrent.com/trials/the-combination-of-pecs-ii-block-and-parasternal-block-for-radical-mastectomy-36320https://curecurrent.com/trials/breast-density-and-the-role-of-preoperative-mammography-ultrasound-elastography-and-mri-36321https://curecurrent.com/trials/sistas-inspiring-sistas-through-activity-and-support-36322https://curecurrent.com/trials/pyrotinib-in-combination-with-nab-paclitaxel-in-patients-with-her2-positive-advanced-breast-cancer-an-exploratory-study-36323https://curecurrent.com/trials/teleconference-group-breast-cancer-in-african-americans-story-36324https://curecurrent.com/trials/hula-a-physical-activity-intervention-for-female-cancer-survivors-36325https://curecurrent.com/trials/digital-breast-tomosynthesis-guided-tomographic-optical-breast-imaging-tobi-36326https://curecurrent.com/trials/vinorelbine-with-trastuzumab-emtansine-in-pre-treated-her2-positive-metastatic-breast-cancer-36327https://curecurrent.com/trials/does-autologous-fat-transplantation-improve-results-and-reduce-complications-in-breast-reconstruction-with-implants-36328https://curecurrent.com/trials/impact-of-a-rehabilitation-programme-for-mothers-with-breast-cancer-and-their-children-36329https://curecurrent.com/trials/initial-evaluation-of-ultra-fast-breast-magnetic-resonance-in-breast-cancer-screening-comparative-study-with-mammography-36330https://curecurrent.com/trials/automated-pain-intervention-for-underserved-minority-breast-cancer-patients-36331https://curecurrent.com/trials/t-dm1-with-abraxane-and-lapatinib-for-metastatic-her2-positive-breast-cancer-36332https://curecurrent.com/trials/emotional-evaluation-and-reconstructed-breast-satisfaction-36333https://curecurrent.com/trials/responsiveness-to-acute-changes-in-exercise-and-relaxation-racer-trial-36334https://curecurrent.com/trials/zoledronic-acid-administration-to-metastatic-breast-cancer-patients-with-non-symptomatic-bone-lesions-36335https://curecurrent.com/trials/collaborative-network-to-take-responsibility-for-oral-anticancer-therapy-36336https://curecurrent.com/trials/panvac-v-and-panvac-f-vaccines-plus-sargramostim-to-treat-advanced-cancer-36337https://curecurrent.com/trials/drain-placement-for-seroma-prevention-after-mammosite-savi-catheter-removal-36338https://curecurrent.com/trials/breast-specific-gamma-imaging-and-locally-advanced-breast-cancer-undergoing-neoadjuvant-chemotherapy-36339https://curecurrent.com/trials/does-the-wording-of-text-message-reminders-improve-uptake-in-breast-screening-36340https://curecurrent.com/trials/a-study-of-abiraterone-acetate-plus-prednisone-with-or-without-exemestane-in-postmenopausal-women-with-estrogen-receptor-36341https://curecurrent.com/trials/an-observational-prospective-cohort-study-using-an-actigraphy-device-36342https://curecurrent.com/trials/breast-cancer-and-chemo-amennorhea-36343https://curecurrent.com/trials/efficacy-and-safety-of-neoadjuvant-dc-t-in-breast-cancer-patients-36344https://curecurrent.com/trials/contrast-enhanced-digital-mammography-cedm-for-identifying-a-change-in-management-of-women-with-newly-diagnosed-breast-c-36345https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-and-ai-in-the-first-line-treatment-of-her2-positive-hr-positive-mbc-36346https://curecurrent.com/trials/a-real-world-clinical-study-of-pyrotinib-maleate-tablets-in-the-treatment-of-breast-cancer-patients-with-positive-her-2-36347https://curecurrent.com/trials/clinical-study-of-utd1-injection-in-combination-with-capecitabine-in-patients-with-advanced-and-metastatic-breast-cancer-36348https://curecurrent.com/trials/trial-of-chemotherapy-and-avastin-as-treatment-for-women-with-breast-cancer-at-high-risk-for-relapse-36349https://curecurrent.com/trials/feasibility-study-of-the-addition-of-a-personal-trainer-to-the-post-treatment-regimen-of-breast-cancer-survivors-36350https://curecurrent.com/trials/assessment-of-fatigue-during-radiotherapy-for-breast-cancer-with-and-without-homeopathy-treatment-36351https://curecurrent.com/trials/canscripttm-clinical-outcomes-in-a-real-world-setting-ancers-2-36352https://curecurrent.com/trials/a-study-of-palbociclib-with-exemestane-plus-gnrh-versus-capecitabine-in-premenopausal-women-with-hr-mbc-36353https://curecurrent.com/trials/endostar-in-combination-with-chemotherapy-in-her-2-negative-advanced-breast-cancer-36354https://curecurrent.com/trials/effectiveness-of-lay-navigators-in-meeting-cancer-patients-non-clinical-needs-a-pilot-study-36355https://curecurrent.com/trials/abbv-085-an-antibody-drug-conjugate-in-subjects-with-advanced-solid-tumors-36356https://curecurrent.com/trials/nuevo-amanecer-ii-translating-a-stress-management-program-for-latinas-36357https://curecurrent.com/trials/study-of-epigallocatechin-3-gallate-egcg-for-skin-prevention-in-patients-with-breast-cancer-receiving-adjuvant-radiother-36358https://curecurrent.com/trials/patient-assisted-compression-in-3d-impact-on-image-quality-and-workflow-36359https://curecurrent.com/trials/acupuncture-for-sleep-disruption-in-cancer-survivors-36360https://curecurrent.com/trials/needs-assessment-after-cancer-in-patients-treated-for-breast-cancer-36361https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-ub-921-in-healthy-volunteers-36362https://curecurrent.com/trials/simvastatin-in-preventing-a-new-breast-cancer-in-women-at-high-risk-for-a-new-breast-cancer-36363https://curecurrent.com/trials/clinical-application-of-ctc-in-operable-breast-cancer-patients-36364https://curecurrent.com/trials/a-study-of-participant-satisfaction-and-safety-with-subcutaneously-administered-trastuzumab-herceptin-in-participants-wi-36365https://curecurrent.com/trials/lapatinib-plus-capecitabine-versus-trastuzumab-plus-capecitabine-in-erbb2-her2-positive-metastatic-breast-cancer-36366https://curecurrent.com/trials/cureone-registry-advanced-malignancy-or-myelodysplasia-tested-by-standard-sequencing-and-treated-by-physician-choice-36367https://curecurrent.com/trials/proof-of-principle-trial-to-determine-if-nutritional-supplement-conjugated-linoleic-acid-cla-can-modulate-the-lipogenic-36368https://curecurrent.com/trials/pilot-study-describing-the-early-evolution-of-the-sexual-function-of-patients-receiving-adjuvant-hormone-therapy-for-bre-36369https://curecurrent.com/trials/a-dose-escalation-study-of-pf-06650808-in-patients-with-advanced-solid-tumors-36370https://curecurrent.com/trials/comparison-to-psychological-medical-and-emotional-influencing-communication-and-achievement-factors-to-oncogenetics-test-36371https://curecurrent.com/trials/biweekly-avastin-and-docetaxel-as-the-first-line-treatment-for-patients-with-metastatic-breast-cancer-36372https://curecurrent.com/trials/dose-adjusted-adjuvant-fec-compared-to-standard-fec-for-breast-cancer-36373https://curecurrent.com/trials/breast-cancer-with-low-risk-of-local-recurrence-partial-and-accelerated-radiation-with-three-dimensional-conformal-radio-36374https://curecurrent.com/trials/risk-factors-for-medium-term-adverse-outcomes-and-predictive-modeling-for-breast-cancer-patients-36375https://curecurrent.com/trials/application-of-ultrasound-artificial-intelligence-and-elastography-in-differential-diagnosis-of-breast-nodules-36376https://curecurrent.com/trials/car-t-hepatic-artery-infusions-and-sir-spheres-for-liver-metastases-36377https://curecurrent.com/trials/hatha-yoga-in-breast-cancer-survivors-36378https://curecurrent.com/trials/sentinel-lymph-node-identification-in-the-axilla-of-women-with-breast-cancer-using-ultrasound-and-iron-injection-36379https://curecurrent.com/trials/robotic-harvest-of-the-latissimus-dorsi-ld-muscles-36380https://curecurrent.com/trials/phase-ii-lapatinib-plus-nab-paclitaxel-as-first-and-second-line-therapy-in-her2-mbc-36381https://curecurrent.com/trials/a-phase-ii-trial-of-ridaforolimus-and-exemestane-compared-to-ridaforolimus-dalotuzumab-and-exemestane-in-participants-wi-36382https://curecurrent.com/trials/pqr309-and-eribulin-in-metastatic-her2-negative-and-triple-negative-breast-cancer-piqhasso-36383https://curecurrent.com/trials/the-trial-comparing-dose-dense-ac-t-with-tp-as-adjuvant-therapy-for-tnbc-with-homologous-recombination-repair-deficiency-36384https://curecurrent.com/trials/neoadjuvant-docetaxel-in-treating-women-with-newly-diagnosed-breast-cancer-36385https://curecurrent.com/trials/tahp-for-patients-with-her2-positive-early-breast-cancer-and-subsequent-ahp-adjuvant-therapy-after-surgery-36386https://curecurrent.com/trials/a-study-on-the-epidemiology-and-testing-of-human-epidermal-growth-factor-receptor-2-her2-in-breast-cancer-in-germany-36387https://curecurrent.com/trials/stereotactic-body-radiation-and-monoclonal-antibody-to-ox40-medi6469-in-breast-cancer-patients-with-metastatic-lesions-36388https://curecurrent.com/trials/comparison-of-perioperative-opioid-consumption-following-pectoral-nerve-block-for-breast-cancer-surgery-36389https://curecurrent.com/trials/enabling-the-study-of-metabolism-in-breast-cancer-through-collection-of-fresh-tissue-biopsies-36390https://curecurrent.com/trials/comparison-of-the-effect-of-total-intravenous-anesthesia-and-inhalation-anesthesia-on-cancer-cell-cytotoxicity-micrometa-36391https://curecurrent.com/trials/pembrolizumab-and-tamoxifen-among-women-with-advanced-hormone-receptor-positive-breast-cancer-and-esr1-mutation-36392https://curecurrent.com/trials/open-label-dose-finding-study-of-trc105-plus-capecitabine-for-metastatic-breast-cancer-36393https://curecurrent.com/trials/american-ginseng-for-the-prevention-of-moderate-severe-fatigue-in-breast-cancer-patients-36394https://curecurrent.com/trials/pyrotinib-combined-with-docetaxel-in-the-first-line-treatment-of-her2-positive-mbc-36395https://curecurrent.com/trials/a-prospective-trial-to-assess-breast-cancer-survivors-and-vaginal-atrophy-treatment-outcomes-36396https://curecurrent.com/trials/a-study-evaluating-the-pf-03084014-in-combination-with-docetaxel-in-patients-with-advanced-breast-cancer-36397https://curecurrent.com/trials/motivational-interviewing-to-increase-physical-activity-behaviour-in-cancer-patients-36398https://curecurrent.com/trials/a-safety-and-immunology-study-of-a-modified-vaccinia-vaccine-for-her-2-breast-cancer-after-adjuvant-therapy-36399https://curecurrent.com/trials/effect-of-pharmacogenomics-differences-in-phase-i-and-ii-metabolism-of-tamoxifen-on-efficacy-and-toxicity-36400https://curecurrent.com/trials/a-safety-and-immunology-study-of-a-modified-vaccinia-vaccine-for-her-2-metastatic-breast-cancer-36401https://curecurrent.com/trials/yoga-practice-for-breast-or-ovarian-cancer-patients-36402https://curecurrent.com/trials/efficacy-study-of-herceptin-to-treat-her2-negative-ctc-breast-cancer-36403https://curecurrent.com/trials/study-comparing-the-safety-and-effectiveness-of-magnetic-resonance-guided-focused-ultrasound-mrgfus-and-external-beam-ra-36404https://curecurrent.com/trials/evaluation-of-adm-soft-tissue-reinforcement-36405https://curecurrent.com/trials/erector-spinae-block-in-segmental-mastectomy-36406https://curecurrent.com/trials/111-indium-chx-a-dtpa-trastuzumab-indium-herceptin-for-imaging-breast-cancer-36407https://curecurrent.com/trials/effects-of-an-integrative-day-care-clinic-program-for-breast-cancer-patients-during-chemotherapy-36408https://curecurrent.com/trials/study-of-glembatumumab-vedotin-cdx-011-in-patients-with-metastatic-gpnmb-over-expressing-triple-negative-breast-cancer-36409https://curecurrent.com/trials/prospective-validation-of-3d-dose-metrics-as-selection-criteria-for-adaptive-radiotherapy-in-breast-cancer-patients-36410https://curecurrent.com/trials/intraoperative-pathway-in-diep-flap-breast-reconstruction-36411https://curecurrent.com/trials/feasibility-of-an-8-week-tai-chi-chuan-intervention-for-breast-cancer-survivors-36412https://curecurrent.com/trials/analgesic-efficacy-of-pulsed-radiofrequency-in-non-cyclic-mastalgia-36413https://curecurrent.com/trials/physiotouch-for-treatment-of-radiation-fibrosis-36414https://curecurrent.com/trials/axillary-ultrasound-with-or-without-sentinel-lymph-node-biopsy-in-detecting-the-spread-of-breast-cancer-in-patients-rece-36415https://curecurrent.com/trials/clinical-study-on-auricular-points-sticking-plus-chinese-medication-for-hot-flashes-in-breast-cancer-women-36416https://curecurrent.com/trials/trastuzumab-and-pertuzumab-or-bevacizumab-with-combination-chemotherapy-in-treating-patients-with-stage-ii-iii-breast-ca-36417https://curecurrent.com/trials/oblimersen-plus-doxorubicin-and-docetaxel-in-treating-patients-with-metastatic-or-locally-advanced-breast-cancer-36418https://curecurrent.com/trials/nepa-to-prevent-chemotherapy-induced-nausea-and-vomiting-in-patients-with-breast-cancer-36419https://curecurrent.com/trials/integrative-approaches-for-cancer-survivorship-2-project-1-36420https://curecurrent.com/trials/fresolimumab-and-radiotherapy-in-metastatic-breast-cancer-36421https://curecurrent.com/trials/integrative-approaches-for-cancer-survivorship-2-project-2-36422https://curecurrent.com/trials/a-pilot-study-on-use-of-liquid-crystal-contact-thermography-to-detect-early-breast-cancer-36423https://curecurrent.com/trials/strain-imaging-in-breast-cancer-patients-receiving-trastuzumab-36424https://curecurrent.com/trials/neoadjuvant-study-of-pyrotinib-and-trastuzumab-plus-chemotherapy-in-patients-with-her2-positive-breast-cancer-36425https://curecurrent.com/trials/yttrium-90-radioembolization-using-glass-microspheres-therasphere-for-patients-with-liver-metastases-36426https://curecurrent.com/trials/neoadjuvant-treatment-of-breast-cancer-36427https://curecurrent.com/trials/oncoplastic-approach-to-excisional-breast-biopsies-36428https://curecurrent.com/trials/image-study-personalized-molecular-profiling-in-cancer-treatment-at-johns-hopkins-36429https://curecurrent.com/trials/the-effect-of-thoracal-paravertebral-block-on-seroma-reduction-in-breast-surgery-36430https://curecurrent.com/trials/a-biomarker-study-in-patients-with-her2-negative-metastatic-breast-cancer-treated-with-bevacizumab-and-paclitaxel-36431https://curecurrent.com/trials/radiation-therapy-in-women-with-low-risk-early-stage-breast-cancer-who-have-undergone-breast-conservation-surgery-36432https://curecurrent.com/trials/radiation-therapy-in-treating-women-with-localized-breast-cancer-36433https://curecurrent.com/trials/her-2-neu-vaccine-plus-gm-csf-in-treating-patients-with-stage-iii-or-stage-iv-breast-ovarian-or-non-small-cell-lung-canc-36434https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-oral-navelbine-in-female-patients-with-her2-negative-metastatic-breast-ca-36435https://curecurrent.com/trials/impact-of-dietary-intervention-on-tumor-immunity-the-digest-trial-36436https://curecurrent.com/trials/assessment-of-diagnostic-accuracy-and-performance-of-digital-breast-tomosynthesis-compared-to-mammography-adapt-36437https://curecurrent.com/trials/breast-cancer-and-exercise-36438https://curecurrent.com/trials/benefit-of-adding-trastuzumab-to-second-line-chemotherapy-in-breast-cancer-patients-previously-treated-with-trastuzumab-36439https://curecurrent.com/trials/an-internet-based-psychosexual-intervention-for-couples-following-treatment-for-breast-cancer-36440https://curecurrent.com/trials/markers-for-predicting-risk-of-breast-cancer-in-women-of-different-races-36441https://curecurrent.com/trials/a-pilot-study-comparison-of-two-hologic-3d-mammography-systems-36442https://curecurrent.com/trials/bridging-the-gap-incorporating-exercise-evidence-into-clinical-practice-in-breast-cancer-care-in-ontario-36443https://curecurrent.com/trials/effects-of-somnage-in-the-management-on-sleep-and-mood-in-cancer-patients-36444https://curecurrent.com/trials/standard-versus-continuous-capecitabine-in-advanced-breast-cancer-36445https://curecurrent.com/trials/increasing-physical-activity-among-breast-cancer-survivors-with-depression-36446https://curecurrent.com/trials/apbi-27gy-in-5-fractions-for-early-breast-cancer-36447https://curecurrent.com/trials/evaluate-risk-benefit-of-nab-paclitaxel-in-combination-with-gemcitabine-and-carboplatin-compared-to-gemcitabine-and-carb-36448https://curecurrent.com/trials/capecitabine-plus-radiotherapy-for-local-relapse-breast-cancer-with-negative-her2-tumours-36449https://curecurrent.com/trials/a-phase-i-open-label-2-part-multicentre-study-to-assess-the-safety-and-efficacy-of-olaparib-in-combination-with-carbopla-36450https://curecurrent.com/trials/red-clover-and-lifestyle-changes-to-contrast-menopausal-symptoms-in-premenopausal-breast-cancer-patients-given-tamoxifen-36451https://curecurrent.com/trials/a-sustainable-approach-to-increasing-cancer-screening-36452https://curecurrent.com/trials/comorbidities-and-health-care-services-utilisation-among-long-term-breast-cancer-survivors-36453https://curecurrent.com/trials/phase-2-study-of-gemzar-taxol-avastin-combination-as-1st-line-treatment-for-metastatic-breast-cancer-36454https://curecurrent.com/trials/triple-negative-breast-cancer-trial-36455https://curecurrent.com/trials/exercise-influence-on-taxane-side-effects-exit-study-36456https://curecurrent.com/trials/local-treatment-in-er-positive-her2-negative-oligo-metastatic-breast-cancer-36457https://curecurrent.com/trials/impact-of-geriatrician-interventions-on-chemotherapy-delivery-in-vulnerable-elderly-oncology-patients-36458https://curecurrent.com/trials/treatment-after-progression-of-fulvestrant-among-metastatic-breast-cancer-patients-36459https://curecurrent.com/trials/measurement-of-the-skin-sympathetic-nerve-activity-36460https://curecurrent.com/trials/recurrence-risk-evaluation-by-21-gene-detection-36461https://curecurrent.com/trials/comparison-of-techniques-for-breast-cancer-related-lymphedema-36462https://curecurrent.com/trials/evaluation-of-persistent-postsurgical-pain-after-breast-surgery-with-a-pectoral-nerves-block-pecs-type-ii-36463https://curecurrent.com/trials/randomized-phase-2-dose-finding-efficacy-safety-study-of-anf-rho-versus-neulasta-in-chemotherapy-induced-neutropenia-36464https://curecurrent.com/trials/a-open-label-multiple-ascending-dose-study-of-ds-3078a-an-oral-torc1-2-kinase-inhibitor-in-subjects-with-advanced-solid-36465https://curecurrent.com/trials/preventing-persistent-pain-and-reducing-depressive-and-anxious-symptoms-following-mastectomy-and-lumpectomy-36466https://curecurrent.com/trials/does-chemotherapy-train-the-mutation-of-the-pig-a-gene-piga-36467https://curecurrent.com/trials/prasterone-dehydroepiandrosterone-in-treating-postmenopausal-cancer-survivors-with-vaginal-symptoms-36468https://curecurrent.com/trials/genetic-risk-whether-when-and-how-to-tell-adolescents-36469https://curecurrent.com/trials/written-genetic-counseling-and-mutation-analysis-of-brca1-and-brca2-to-patients-with-breast-cancer-36470https://curecurrent.com/trials/effect-of-increased-light-exposure-on-fatigue-in-breast-cancer-36471https://curecurrent.com/trials/an-enhanced-artificial-intelligence-breast-mri-interpretation-system-36472https://curecurrent.com/trials/evaluating-and-following-breast-cancer-patients-in-a-better-way-36473https://curecurrent.com/trials/physical-and-psychological-effects-of-different-temperature-controlled-breast-prostheses-on-patients-with-breast-cancer-36474https://curecurrent.com/trials/assessment-of-diagnostic-accuracy-and-performance-of-digital-breast-tomosynthesis-compared-to-mammography-36475https://curecurrent.com/trials/cyp17-lyase-and-androgen-receptor-inhibitor-treatment-with-seviteronel-trial-ino-vt-464-006-nct02580448-36476https://curecurrent.com/trials/pilates-method-on-the-upper-limbs-functionality-36477https://curecurrent.com/trials/capecitabine-in-the-treatment-of-breast-cancer-with-low-hormone-receptor-expression-after-neoadjuvant-chemotherapy-36478https://curecurrent.com/trials/effect-of-therapeutic-massage-on-sleep-quality-and-stress-levels-in-women-with-breast-cancer-36479https://curecurrent.com/trials/metastatic-breast-cancer-treatment-planning-36480https://curecurrent.com/trials/the-malaysian-soy-and-mammographic-density-study-36481https://curecurrent.com/trials/hypofractionated-radiation-therapy-with-concomitant-boost-in-treating-women-after-breast-conserving-surgery-36482https://curecurrent.com/trials/gw572016-in-patients-with-erbb2-over-expressing-advanced-or-metastatic-breast-cancer-36483https://curecurrent.com/trials/tomosynthesis-versus-digital-mammography-in-a-population-based-screening-program-36484https://curecurrent.com/trials/comparing-3-d-printed-vs-standard-bolus-for-breast-cancer-chest-wall-radiotherapy-36485https://curecurrent.com/trials/standard-care-alone-or-with-acupuncture-for-cipn-in-breast-cancer-and-multiple-myeloma-36486https://curecurrent.com/trials/cbpr-brca-genetic-testing-among-orthodox-jews-36487https://curecurrent.com/trials/use-of-a-remifentanil-propofol-mixture-in-patients-undergoing-breast-cancer-surgery-36488https://curecurrent.com/trials/a-phase-iii-study-of-bkm120-with-fulvestrant-in-patients-with-hr-her2-ai-treated-locally-advanced-or-metastatic-breast-c-36489https://curecurrent.com/trials/improving-surgical-medical-oncology-collaboration-for-breast-cancer-treatment-planning-pilot-testing-the-impact-of-conti-36490https://curecurrent.com/trials/airxpanders-aeroform-tissue-expander-system-for-breast-reconstruction-36491https://curecurrent.com/trials/assessment-of-diagnostic-accuracy-and-performance-of-digital-breast-tomosynthesis-compared-to-mammography-36492https://curecurrent.com/trials/atypical-lesions-of-the-breast-close-observation-versus-excision-alcove-36493https://curecurrent.com/trials/breast-cancer-women-on-aromatase-inhibitors-treatment-36494https://curecurrent.com/trials/bioinformation-therapy-for-breast-cancer-36495https://curecurrent.com/trials/health-education-intervention-in-reducing-weight-gain-in-patients-with-newly-diagnosed-stage-i-iv-breast-cancer-undergoi-36496https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-eribulin-in-korean-breast-cancer-participants-36497https://curecurrent.com/trials/contrast-enhanced-ultrasound-and-shear-wave-elastography-in-measuring-response-in-patients-with-breast-cancer-receiving-36498https://curecurrent.com/trials/circulating-osteocalcin-positive-cells-in-breast-cancer-bone-metastasis-36499https://curecurrent.com/trials/breast-density-hormone-levels-and-anticancer-drug-levels-in-women-with-invasive-breast-cancer-who-are-receiving-exemesta-36500https://curecurrent.com/trials/tamoxifen-in-preventing-breast-cancer-in-women-at-increased-risk-for-breast-cancer-36501https://curecurrent.com/trials/prophylactic-treatment-of-sleep-fatigue-before-and-during-chemotherapy-36502https://curecurrent.com/trials/bkm120-for-triple-negative-breast-cancer-36503https://curecurrent.com/trials/combination-chemotherapy-and-paclitaxel-plus-trastuzumab-in-treating-women-with-palpable-breast-cancer-that-can-be-remov-36504https://curecurrent.com/trials/trastuzumab-and-vinorelbine-in-advanced-breast-cancer-36505https://curecurrent.com/trials/follow-up-of-elderly-patients-in-ambulatory-surgery-36506https://curecurrent.com/trials/increase-surveillance-for-breast-and-ovarian-cancers-also-to-determine-targeted-risk-reducing-and-preventative-strategie-36507https://curecurrent.com/trials/radiation-therapy-after-surgery-in-treating-women-with-phyllodes-tumor-of-the-breast-36508https://curecurrent.com/trials/the-uk-plasma-based-molecular-profiling-of-advanced-breast-cancer-to-inform-therapeutic-choices-plasmamatch-trial-36509https://curecurrent.com/trials/trial-of-partial-breast-irradiation-with-various-concurrent-chemotherapy-regimens-36510https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-bevacizumab-and-associated-biomarkers-in-combination-with-paclitaxel-compar-36511https://curecurrent.com/trials/comparison-of-cnb-and-surgical-specimens-for-er-pgr-her2-status-and-ki67-index-in-invasive-breast-cancer-36512https://curecurrent.com/trials/added-value-of-contrast-enhanced-spectral-mammography-cesm-a-pilot-study-36513https://curecurrent.com/trials/cyclophosphamide-and-cryoablation-in-treating-patients-with-advanced-or-metastatic-epithelial-cancer-36514https://curecurrent.com/trials/the-efficacy-and-safety-of-peg-rhg-csf-pegylated-recombinant-human-granulocyte-colony-stimulating-factor-in-patients-wit-36515https://curecurrent.com/trials/vivomixx-for-prevention-of-bone-loss-in-women-with-breast-cancer-treated-with-an-aromatase-inhibitor-36516https://curecurrent.com/trials/presurgical-treatment-with-letrozole-in-patients-with-early-stage-breast-cancer-36517https://curecurrent.com/trials/non-interventional-study-evaluating-gynecological-impact-of-diagnosis-and-treatment-of-breast-cancer-in-patients-younger-36518https://curecurrent.com/trials/topical-doxepin-for-radiation-induced-dermatitis-36519https://curecurrent.com/trials/phase-i-of-carboplatin-olaparib-followed-by-olaparib-monotherapy-in-advanced-cancer-36520https://curecurrent.com/trials/combined-training-intervention-for-women-who-underwent-primary-treatment-for-breast-cancer-36521https://curecurrent.com/trials/preoperative-herceptin-and-navelbine-for-breast-cancer-36522https://curecurrent.com/trials/nuevo-amanecer-promoting-the-psychosocial-health-of-latinas-36523https://curecurrent.com/trials/combined-breast-cancer-risk-study-36524https://curecurrent.com/trials/evaluation-of-the-predictive-and-prognostic-value-of-germ-line-polymorphisms-in-patients-with-metastatic-breast-cancer-36525https://curecurrent.com/trials/adapted-physical-activity-effect-on-aerobic-function-and-fatigue-at-home-in-patients-with-breast-cancer-treated-in-adjuv-36526https://curecurrent.com/trials/a-combined-gwas-and-mirna-for-the-identification-of-bevacizumab-response-predictors-in-metastatic-breast-cancer-36527https://curecurrent.com/trials/a-study-to-determine-the-safety-of-btp-114-for-treatment-in-patients-with-advanced-solid-tumors-with-brca-mutations-36528https://curecurrent.com/trials/clinical-study-on-anti-tumor-effect-induced-by-activated-primary-natural-killer-nk-cells-36529https://curecurrent.com/trials/whey-protein-supplement-in-combination-with-physical-exercise-and-nutrition-program-36530https://curecurrent.com/trials/cardiac-magnetic-resonance-for-early-detection-of-chemotherapy-or-radiation-therapy-induced-cardiotoxicity-in-breast-can-36531https://curecurrent.com/trials/development-of-distress-management-algorithms-using-mobile-device-based-health-logs-in-breast-cancer-survivors-36532https://curecurrent.com/trials/albumin-bound-paclitaxel-followed-by-epirubicin-in-combination-with-cyclophosphamide-in-triple-negative-breast-cancer-36533https://curecurrent.com/trials/using-bupivacaine-locally-in-the-mastectomy-drains-to-control-postoperative-pain-36534https://curecurrent.com/trials/study-of-talazoparib-a-parp-inhibitor-in-patients-with-advanced-or-recurrent-solid-tumors-36535https://curecurrent.com/trials/development-of-exercise-promotion-program-using-a-mobile-community-36536https://curecurrent.com/trials/albumin-bound-paclitaxel-combined-with-carboplatin-as-neoadjuvant-chemotherapy-in-luminal-b-her-2-negative-breast-cancer-36537https://curecurrent.com/trials/role-of-sorcin-and-annexin-a3-in-breast-cancer-patients-36538https://curecurrent.com/trials/a-study-of-pf-06263507-in-patients-with-advanced-solid-tumors-36539https://curecurrent.com/trials/solti-breast-cancer-molecular-screening-program-agata-36540https://curecurrent.com/trials/cardiotoxicity-of-radiation-therapy-ctrt-36541https://curecurrent.com/trials/pilot-study-assessing-breast-temperature-in-breast-cancer-patients-36542https://curecurrent.com/trials/a-study-evaluating-pf-03084014-in-patients-with-advanced-breast-cancer-with-or-without-notch-alterations-36543https://curecurrent.com/trials/online-mindfulness-for-women-treated-for-breast-cancer-and-men-treated-for-prostate-cancer-36544https://curecurrent.com/trials/a-study-of-pf-05280014-or-trastuzumab-plus-taxotere-and-carboplatin-in-her2-positive-breast-cancer-in-the-neoadjuvant-se-36545https://curecurrent.com/trials/exploratory-study-to-assess-the-short-term-intratumoural-and-peripheral-effects-of-bn83495-in-postmenopausal-women-with-36546https://curecurrent.com/trials/prognosis-and-targeted-therapy-related-molecular-screening-program-for-patients-of-breast-cancer-in-china-36547https://curecurrent.com/trials/circadian-thermal-sensing-to-detect-breast-disease-36548https://curecurrent.com/trials/18f-fspg-pet-ct-for-cancer-patients-on-therapy-36549https://curecurrent.com/trials/a-multi-center-study-of-ibrutinib-in-combination-with-medi4736-in-subjects-with-relapsed-or-refractory-solid-tumors-36550https://curecurrent.com/trials/trial-of-oral-hyaluronic-acid-for-the-prevention-of-aromatase-inhibitor-associated-arthralgias-36551https://curecurrent.com/trials/informative-tools-to-optimize-neoadjuvant-therapy-in-er-positive-her2-negative-breast-cancers-36552https://curecurrent.com/trials/minimally-invasive-biopsy-predicting-breast-pcr-after-nac-for-breast-cancer-36553https://curecurrent.com/trials/dose-escalating-study-of-foxy-5-in-breast-colon-or-prostate-cancer-patients-36554https://curecurrent.com/trials/persistent-post-surgical-pain-in-women-with-brca-36555https://curecurrent.com/trials/persistant-organics-pollutants-in-breast-cancer-36556https://curecurrent.com/trials/endocrine-therapy-in-treating-patients-with-her2-negative-low-risk-breast-cancer-36557https://curecurrent.com/trials/prophylactic-use-of-peg-rhg-csf-in-medium-high-risk-of-fn-in-chemotherapy-of-breast-cancer-36558https://curecurrent.com/trials/correlation-between-circulating-tumor-cells-and-brain-disease-control-after-focal-radiotherapy-for-metastases-of-breast-36559https://curecurrent.com/trials/blood-glycan-biomarkers-in-women-with-stage-iv-breast-cancer-36560https://curecurrent.com/trials/chemotherapy-and-progenitor-cell-transplantation-to-treat-inflammatory-breast-cancer-36561https://curecurrent.com/trials/safety-study-of-the-hypo-fractionated-large-doses-radiation-therapy-in-post-menopausal-women-with-breast-cancers-36562https://curecurrent.com/trials/pilot-feasibility-study-of-an-online-lifestyle-intervention-for-overweight-breast-cancer-survivors-36563https://curecurrent.com/trials/expanded-access-study-of-palbociclib-pd-0332991-in-combination-with-letrozole-as-treatment-of-post-menopausal-women-with-36564https://curecurrent.com/trials/isolation-of-circulating-tumor-cells-using-a-novel-emt-based-capture-method-36565https://curecurrent.com/trials/effectiveness-of-liquid-crystal-contact-thermography-in-detecting-pathological-changes-in-female-breasts-36566https://curecurrent.com/trials/shearwave-elastography-of-breast-lesions-in-chinese-patients-36567https://curecurrent.com/trials/diagnostic-accuracy-of-dermal-thickness-in-lymphedema-36568https://curecurrent.com/trials/fluciclovine-18f-imaging-of-breast-cancer-36569https://curecurrent.com/trials/akt-inhibitor-mk2206-in-treating-patients-with-advanced-breast-cancer-36570https://curecurrent.com/trials/study-of-body-composition-in-patients-treated-by-adjuvant-hormonal-therapy-for-breast-cancer-metaca2-36571https://curecurrent.com/trials/everolimus-in-combination-with-trastuzumab-and-paclitaxel-in-the-treatment-of-her2-positive-locally-advanced-or-metastat-36572https://curecurrent.com/trials/parallel-comparison-of-18-gene-classifiers-and-oncotype-dx-nanostring-36573https://curecurrent.com/trials/a-study-of-sc-005-in-subjects-with-triple-negative-breast-cancer-tnbc-36574https://curecurrent.com/trials/a-study-of-everolimus-trastuzumab-and-vinorelbine-in-her2-positive-breast-cancer-brain-metastases-36575https://curecurrent.com/trials/compare-apatinib-plus-capecitabine-versus-capecitabine-in-maintenance-therapy-for-patients-with-advanced-triple-negative-36576https://curecurrent.com/trials/changes-in-knee-articular-cartilage-volume-in-women-on-aromatase-inhibitors-36577https://curecurrent.com/trials/carboplatin-and-bevacizumab-for-progressive-breast-cancer-brain-metastases-36578https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-the-epigenetic-modifying-effects-of-cc-486-oral-azacitidine-in-combination-wi-36579https://curecurrent.com/trials/prevention-using-exercise-rehabilitation-to-offset-cardiac-toxicities-induced-via-chemotherapy-36580https://curecurrent.com/trials/four-conversations-rct-36581https://curecurrent.com/trials/study-to-compare-zoladex-10-8-mg-with-zoladex-3-6-mg-in-pre-menopausal-women-with-breast-cancer-36582https://curecurrent.com/trials/clinical-study-on-drug-sensitivity-verification-or-prediction-of-therapy-for-breast-cancer-by-patient-derived-organoid-m-36583https://curecurrent.com/trials/the-value-of-18f-fes-pet-ct-in-predicting-fulvestrant-efficacy-in-breast-cancer-36584https://curecurrent.com/trials/abraxane-combined-with-xeloda-as-neo-adjuvant-chemotherapy-in-early-breast-cancer-36585https://curecurrent.com/trials/the-efficacy-and-safety-of-abraxane-combined-with-epirubicin-as-neoadjuvant-chemotherapy-in-breast-cancer-36586https://curecurrent.com/trials/the-combination-of-palbociclib-with-ddec-p-as-neoadjuvant-therapy-in-triple-negative-breast-cancer-36587https://curecurrent.com/trials/influence-of-exceptional-patient-characteristics-on-everolimus-exposure-36588https://curecurrent.com/trials/trends-of-mastectomy-and-breast-conserving-surgery-in-female-breast-cancer-patients-36589https://curecurrent.com/trials/nano-mri-on-7-tesla-in-rectal-and-breast-cancer-36590https://curecurrent.com/trials/nexium-study-to-suppress-nausea-during-chemotherapy-36591https://curecurrent.com/trials/phase-ii-study-of-eribulin-mesylate-trastuzumab-and-pertuzumab-in-women-with-metastatic-unresectable-locally-advanced-or-36592https://curecurrent.com/trials/muslim-americans-reaching-for-health-and-building-alliances-marhaba-patient-navigation-intervention-to-increase-breast-a-36593https://curecurrent.com/trials/a-phase-1-dose-escalation-study-of-the-safety-tolerability-and-pharmacokinetics-of-intravenous-dimethane-sulfonate-dms61-36594https://curecurrent.com/trials/phase-ii-trial-of-everolimus-trastuzumab-in-hormone-refractory-metastatic-breast-cancer-36595https://curecurrent.com/trials/ontak-in-treating-patients-with-advanced-breast-cancer-that-did-not-respond-to-previous-treatment-36596https://curecurrent.com/trials/nab-paclitaxel-and-bevacizumab-followed-by-bevacizumab-and-erlotinib-in-metastatic-breast-cancer-36597https://curecurrent.com/trials/paclitaxel-and-carboplatin-in-treating-women-who-are-undergoing-surgery-for-newly-diagnosed-locally-advanced-breast-canc-36598https://curecurrent.com/trials/speeding-recovery-from-pain-and-opioid-use-36599https://curecurrent.com/trials/nutritional-status-and-pharmacological-treatment-impact-on-the-toxicity-and-quality-of-life-of-patients-with-colorectal-36600https://curecurrent.com/trials/a-study-evaluating-the-safety-pharmacokinetics-and-anti-tumor-activity-of-abbv-176-in-subjects-with-advanced-solid-tumor-36601https://curecurrent.com/trials/prospr-pcips-project-3-communication-of-personalized-breast-cancer-risk-36602https://curecurrent.com/trials/management-of-insomnia-in-breast-cancer-patients-36603https://curecurrent.com/trials/kadcyla-in-patients-with-brain-metastasis-36604https://curecurrent.com/trials/usg-pecs-vs-lia-for-breast-cancer-surgery-36605https://curecurrent.com/trials/a-safety-and-efficacy-study-of-bcd-022-with-paclitaxel-compared-to-herceptin-with-paclitaxel-in-her2-metastatic-breast-c-36606https://curecurrent.com/trials/hybrid-pet-mr-imaging-of-acute-cardiac-inflammation-after-left-sided-breast-cancer-radiotherapy-36607https://curecurrent.com/trials/a-study-to-evaluate-denosumab-in-young-patients-with-primary-breast-cancer-36608https://curecurrent.com/trials/study-of-the-pharmacokinetics-and-safety-of-trastuzumab-emtansine-in-chinese-participants-with-locally-advanced-inoperab-36609https://curecurrent.com/trials/4d-image-guided-partial-breast-radiation-in-stage-0-and-l-breast-cancer-36610https://curecurrent.com/trials/study-to-evaluate-the-effect-of-sulforaphane-in-broccoli-sprout-extract-on-breast-tissue-36611https://curecurrent.com/trials/denosumab-in-treating-patients-with-er-and-or-pr-positive-her2-negative-metastatic-breast-cancer-with-bone-metastases-an-36612https://curecurrent.com/trials/circulating-tumor-dna-exposure-in-peripheral-blood-36613https://curecurrent.com/trials/htert-immunotherapy-alone-or-in-combination-with-il-12-dna-followed-by-electroporation-in-adults-with-solid-tumors-at-hi-36614https://curecurrent.com/trials/capsule-biopsy-in-acellular-dermal-matrix-based-prosthetic-breast-reconstruction-a-prospective-pilot-study-36615https://curecurrent.com/trials/safety-immunogenicity-and-pharmacokinetics-of-syn004-in-patients-with-solid-tumors-36616https://curecurrent.com/trials/routine-therapy-plus-moxifloxacin-in-advanced-breast-cancer-36617https://curecurrent.com/trials/effect-of-radiation-and-its-timing-on-breast-reconstruction-in-chinese-patients-36618https://curecurrent.com/trials/application-of-intra-operative-prophylactic-antibiotics-antiseptics-in-chinese-breast-reconstruction-patients-36619https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-eribulin-mesylate-administered-biweekly-q2w-for-participants-with-human-epi-36620https://curecurrent.com/trials/gemcitabine-and-liposomal-doxorubicin-in-treating-women-with-metastatic-breast-cancer-36621https://curecurrent.com/trials/acupressure-in-treating-nausea-in-women-receiving-combination-chemotherapy-for-breast-cancer-36622https://curecurrent.com/trials/inherited-susceptible-genes-among-epithelial-ovarian-cancer-36623https://curecurrent.com/trials/study-of-high-dose-letrozole-therapy-in-postmenopausal-patients-with-breast-cancer-36624https://curecurrent.com/trials/sensation-after-nipple-sparing-mastectomy-and-breast-reconstruction-with-or-without-neurotized-free-tissue-transfer-36625https://curecurrent.com/trials/use-of-clorhexidine-dressings-to-reduce-surgical-site-infections-in-breast-cancer-surgery-a-controlled-clinical-trial-36626https://curecurrent.com/trials/empathy-and-standard-diagnostic-procedures-in-an-outpatient-breast-clinic-might-not-be-enough-36627https://curecurrent.com/trials/apatinib-combined-with-paclitaxel-and-carbopatin-intensive-regimen-in-neoadjuvant-therapy-for-locally-advanced-triple-ne-36628https://curecurrent.com/trials/igar-breast-teleop-trial-36629https://curecurrent.com/trials/immunotherapy-for-the-treatment-of-breast-cancer-related-upper-extremity-lymphedema-bcrl-36630https://curecurrent.com/trials/a-trial-of-a-comprehensive-breast-cancer-treatment-patient-decision-tool-36631https://curecurrent.com/trials/genomic-and-proteomic-profiling-targets-influenced-treatment-in-metastatic-breast-cancer-36632https://curecurrent.com/trials/capecitabine-bendamustine-in-women-with-pretreated-locally-advanced-or-metastatic-her2-negative-breast-cancer-36633https://curecurrent.com/trials/zoledronic-acid-in-treating-patients-with-metastatic-breast-cancer-metastatic-prostate-cancer-or-multiple-myeloma-with-b-36634https://curecurrent.com/trials/fenretinide-in-healthy-young-women-at-genetic-and-familial-risk-36635https://curecurrent.com/trials/filgrastim-plus-chemotherapy-compared-with-filgrastim-alone-in-treating-women-undergoing-peripheral-stem-cell-transplant-36636https://curecurrent.com/trials/behavioral-symptom-management-program-for-breast-cancer-in-singapore-and-the-us-36637https://curecurrent.com/trials/phase-iii-trial-comparing-capecitabine-in-combination-with-sorafenib-or-placebo-in-the-treatment-of-locally-advanced-or-36638https://curecurrent.com/trials/the-lightpath-and-68ga-rm2-in-breast-cancer-study-36639https://curecurrent.com/trials/medi4736-durvalumab-in-patients-with-brain-metastasis-from-epithelial-derived-tumors-36640https://curecurrent.com/trials/pre-operative-zoledronate-in-triple-negative-breast-cancer-36641https://curecurrent.com/trials/multi-catheter-high-dose-rate-hdr-breast-brachytherapy-36642https://curecurrent.com/trials/prevention-of-body-image-disorder-by-nurse-intervention-on-the-patient-and-family-prior-to-breast-and-colon-surgery-36643https://curecurrent.com/trials/evaluation-of-canadvice-m-health-system-to-support-breast-cancer-patients-receiving-capecitabine-36644https://curecurrent.com/trials/emerging-from-the-haze-measuring-the-impact-of-a-psycho-education-program-on-perceived-cognition-after-breast-cancer-tre-36645https://curecurrent.com/trials/tipifarnib-and-fulvestrant-in-hormone-receptor-positive-metastatic-breast-cancer-36646https://curecurrent.com/trials/nutritional-supplements-and-hormonal-manipulations-for-breast-cancer-prevention-36647https://curecurrent.com/trials/a-study-to-evaluate-exemestane-tablets-combined-with-ovarian-function-suppression-ablation-in-treatment-of-premenopausal-36648https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-previously-treated-stage-ii-or-stage-iii-breast-cancer-36649https://curecurrent.com/trials/thermal-suit-with-forced-air-warming-in-breast-cancer-surgery-36650https://curecurrent.com/trials/a-prospective-validation-study-of-a-rapid-point-of-care-breath-test-for-breast-cancer-36651https://curecurrent.com/trials/shoulder-disability-and-late-symptoms-following-oncoplastic-breast-surgery-36652https://curecurrent.com/trials/automated-breast-ultrasound-as-an-adjunct-to-screening-digital-breast-tomosynthesis-36653https://curecurrent.com/trials/pilot-study-of-an-intimacy-enhancement-intervention-for-couples-facing-breast-cancer-36654https://curecurrent.com/trials/low-energy-dissection-vs-electrocautery-in-lumpectomy-shaved-surgical-margins-36655https://curecurrent.com/trials/complete-decongestive-therapy-in-breast-cancer-related-lymphedema-36656https://curecurrent.com/trials/postoperative-analgesia-impact-of-narcotic-free-anesthesia-36657https://curecurrent.com/trials/a-study-to-compare-the-effect-of-sb3-and-herceptin-in-women-with-her2-positive-breast-cancer-36658https://curecurrent.com/trials/randomized-study-on-postmenopausal-women-with-early-stage-breast-cancer-wbi-versus-apbi-36659https://curecurrent.com/trials/weight-bearing-exercise-in-preventing-frailty-in-stage-i-iiia-breast-cancer-survivors-36660https://curecurrent.com/trials/a-study-of-the-safety-and-effects-of-one-or-more-doses-of-hsp-130-injected-under-the-skin-in-women-with-breast-cancer-th-36661https://curecurrent.com/trials/evaluating-patient-information-prescriptions-36662https://curecurrent.com/trials/dead-space-closure-with-quilting-suture-versus-conventional-closure-with-drainage-36663https://curecurrent.com/trials/efficacy-and-safety-study-of-enzalutamide-in-combination-with-paclitaxel-chemotherapy-or-as-monotherapy-versus-placebo-w-36664https://curecurrent.com/trials/efficacy-and-safety-of-dignicap-system-36665https://curecurrent.com/trials/a-study-of-the-proper-dosage-of-lovastatin-and-docetaxel-for-patients-with-cancer-36666https://curecurrent.com/trials/efficacy-of-a-smart-management-strategy-for-health-smash-program-for-overcoming-cancer-crisis-and-growing-positively-36667https://curecurrent.com/trials/amg-162-in-the-treatment-of-bone-loss-in-subjects-undergoing-aromatase-inhibitor-therapy-for-non-metastatic-breast-cance-36668https://curecurrent.com/trials/a-study-of-ipatasertib-gdc-0068-in-combination-with-paclitaxel-as-neoadjuvant-treatment-for-participants-with-early-stag-36669https://curecurrent.com/trials/pilot-study-estradiol-followed-by-exemestane-hormone-receptor-metastatic-breast-cancer-36670https://curecurrent.com/trials/couples-based-mindfulness-for-young-breast-cancer-survivors-36671https://curecurrent.com/trials/study-of-denosumab-in-the-treatment-of-hypercalcemia-of-malignancy-in-subjects-with-elevated-serum-calcium-36672https://curecurrent.com/trials/impact-of-tumor-bed-localisation-on-dosimetry-boost-irradiation-in-patients-undergoing-breast-conserving-surgery-36673https://curecurrent.com/trials/letrozole-in-treating-postmenopausal-women-with-stage-i-ii-or-iii-breast-cancer-that-can-be-removed-by-surgery-36674https://curecurrent.com/trials/locally-advanced-breast-cancer-individualized-treatment-based-on-tumor-molecular-characteristics-36675https://curecurrent.com/trials/capecitabine-versus-vinorelbine-in-high-risk-breast-cancer-with-pathologic-residual-tumors-after-preoperative-chemothera-36676https://curecurrent.com/trials/efficacy-of-cardio-oncology-rehabilitation-exercise-for-women-with-breast-cancer-and-treatment-related-cardiotoxicity-36677https://curecurrent.com/trials/phase-i-dose-escalation-of-oral-bay1161909-in-combination-with-intravenous-paclitaxel-36678https://curecurrent.com/trials/the-use-of-pycnogenol-to-alleviate-menopausal-symptoms-induced-or-increased-by-breast-and-gynecological-cancer-treatment-36679https://curecurrent.com/trials/a-phase-randomized-clinical-trial-of-postmastectomy-hypofractionation-radiotherapy-in-high-risk-breast-cancer-36680https://curecurrent.com/trials/dce-mri-and-dwi-for-detection-and-diagnosis-of-breast-cancer-36681https://curecurrent.com/trials/multi-scale-modeling-of-breast-conserving-therapy-36682https://curecurrent.com/trials/treating-patients-with-advanced-solid-tumors-breast-cancer-or-recurrent-ovarian-cancer-36683https://curecurrent.com/trials/self-management-interventions-for-advanced-breast-cancer-36684https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-previously-treated-stage-ii-iii-her2-positive-breast-cancer-36685https://curecurrent.com/trials/single-photon-emission-computed-tomography-computed-tomography-lymphoscintigraphy-and-intensity-modulated-radiation-ther-36686https://curecurrent.com/trials/support-group-program-in-improving-quality-of-life-in-underserved-urban-latina-breast-cancer-survivors-36687https://curecurrent.com/trials/a-communication-skills-package-to-prevent-fear-of-cancer-recurrence-36688https://curecurrent.com/trials/the-role-of-two-different-metronomic-chemotherapy-regimens-in-locally-advanced-or-metastatic-triple-negative-breast-canc-36689https://curecurrent.com/trials/study-of-previously-collected-and-stored-tissue-samples-from-patients-previously-enrolled-in-a-completed-national-cancer-36690https://curecurrent.com/trials/studying-biomarkers-in-nipple-fluid-urine-and-blood-samples-from-women-with-newly-diagnosed-ductal-carcinoma-in-situ-or-36691https://curecurrent.com/trials/outcome-of-neo-adjuvant-chemotherapy-followed-by-breast-conservative-surgery-in-breast-cancer-in-upper-egypt-36692https://curecurrent.com/trials/improving-adherence-to-recommended-surveillance-in-breast-cancer-survivors-36693https://curecurrent.com/trials/dose-finding-trial-of-f-627-in-women-with-breast-cancer-receiving-myelotoxic-chemotherapy-36694https://curecurrent.com/trials/tissue-expander-implant-reconstruction-a-single-blinded-randomized-controlled-trial-36695https://curecurrent.com/trials/alisertib-and-fulvestrant-in-treating-patients-with-hormone-receptor-positive-breast-cancer-that-is-metastatic-or-locall-36696https://curecurrent.com/trials/ltx-315-in-patients-with-transdermally-accessible-tumours-as-monotherapy-or-combination-with-ipilimumab-or-pembrolizumab-36697https://curecurrent.com/trials/safety-and-efficacy-of-sct200-in-patients-with-relapsed-or-metastatic-triple-receptor-negative-breast-cancer-36698https://curecurrent.com/trials/redes-iii-patient-navigator-qol-study-36699https://curecurrent.com/trials/fear-of-cancer-recurrence-for-trajectory-during-radiation-treatment-36700https://curecurrent.com/trials/arm-circumference-measurement-with-or-without-bioimpedance-spectroscopy-in-finding-lymphedema-early-in-patients-with-sta-36701https://curecurrent.com/trials/iodine-supplementation-on-breast-cancer-36702https://curecurrent.com/trials/neoadjuvant-aromatase-inhibitor-and-pertuzumab-trastuzumab-for-women-with-breast-cancer-36703https://curecurrent.com/trials/potential-of-circulating-tumor-dna-to-assess-the-tumor-response-to-neoadjuvant-chemotherapy-in-breast-cancer-patients-36704https://curecurrent.com/trials/lifestyle-intervention-study-in-adjuvant-treatment-of-early-breast-cancer-36705https://curecurrent.com/trials/temsirolimus-plus-neratinib-for-patients-with-metastatic-her2-amplified-or-triple-negative-breast-cancer-36706https://curecurrent.com/trials/capecitabine-in-her-2-positive-breast-cancer-with-pathologic-residual-tumors-after-preoperative-chemotherapy-36707https://curecurrent.com/trials/pegi-to-improve-shared-decision-making-for-breast-reconstruction-36708https://curecurrent.com/trials/trastuzumab-cyclophosphamide-and-vaccine-therapy-in-treating-patients-with-high-risk-or-metastatic-breast-cancer-36709https://curecurrent.com/trials/role-of-ultrasound-guided-lymph-node-biopsy-in-axillary-staging-of-breast-cancer-36710https://curecurrent.com/trials/informed-implementation-of-breast-density-reporting-36711https://curecurrent.com/trials/effect-of-perioperative-low-dose-ketamine-on-postoperative-recovery-in-patients-undergoing-breast-cancer-surgery-36712https://curecurrent.com/trials/tpi-287-in-breast-cancer-metastatic-to-the-brain-36713https://curecurrent.com/trials/anastrozole-or-tamoxifen-in-treating-postmenopausal-women-with-ductal-carcinoma-in-situ-who-are-undergoing-lumpectomy-an-36714https://curecurrent.com/trials/phase-0-study-of-metronomic-oral-vinorelbine-and-letrozole-in-hr-her2-negative-early-breast-cancer-patients-ventana-36715https://curecurrent.com/trials/estrogen-priming-to-increase-the-efficacy-of-adjuvant-chemotherapy-in-operable-breast-cancer-36716https://curecurrent.com/trials/pam50-her2-enriched-phenotype-as-a-predictor-of-response-to-dual-her2-blockade-in-her2-positive-early-breast-cancer-36717https://curecurrent.com/trials/tamoxifen-gnrh-analogue-vs-aromatase-inhibitor-gnrh-analogue-in-male-breast-cancer-patients-36718https://curecurrent.com/trials/first-in-human-dose-escalation-trial-in-subjects-with-advanced-malignancies-36719https://curecurrent.com/trials/zr-df-iab22m2c-pet-ct-in-patients-with-selected-solid-malignancies-or-hodgkin-s-lymphoma-36720https://curecurrent.com/trials/preoperative-study-with-trastuzumab-pertuzumab-and-letrozole-in-breast-cancer-patients-sensitive-to-hormonal-therapy-36721https://curecurrent.com/trials/131iodine-tenatumomab-treatment-in-tenascin-c-positive-cancer-patients-36722https://curecurrent.com/trials/trastuzumab-or-lapatinib-ditosylate-in-treating-women-with-early-breast-cancer-36723https://curecurrent.com/trials/study-of-the-influence-of-ductal-carcinoma-in-situ-on-the-outcome-of-invasive-breast-cancer-36724https://curecurrent.com/trials/lapatinib-in-combination-with-capecitabine-in-japanese-patients-with-metastatic-breast-cancer-36725https://curecurrent.com/trials/study-evaluating-hki-272-in-tumors-36726https://curecurrent.com/trials/role-of-early-versus-late-switch-to-lapatinib-capecitabine-36727https://curecurrent.com/trials/preventive-intervention-against-lymphedema-after-breast-cancer-surgery-36728https://curecurrent.com/trials/breast-cancer-with-over-expression-of-erbb2-brainstorm-36729https://curecurrent.com/trials/study-of-neoadjuvant-docetaxel-and-cyclophosphamide-in-locally-advanced-or-node-positive-primary-breast-cancer-with-comp-36730https://curecurrent.com/trials/study-of-letrozole-with-or-without-byl719-or-buparlisib-for-the-neoadjuvant-treatment-of-postmenopausal-women-36731https://curecurrent.com/trials/dose-escalation-of-pol6326-in-combination-with-eribulin-in-patients-with-metastatic-breast-cancer-36732https://curecurrent.com/trials/a-study-of-pertuzumab-and-trastuzumab-subcutaneous-sc-treatment-in-combination-with-a-taxane-in-participants-with-human-36733https://curecurrent.com/trials/no-axillary-surgery-for-early-breast-cancer-36734https://curecurrent.com/trials/a-phase-ib-ii-study-of-the-combination-of-byl719-plus-amg-479-in-adult-patients-with-selected-solid-tumors-36735https://curecurrent.com/trials/dermacell-adm-without-basement-membrane-36736https://curecurrent.com/trials/zoledronic-acid-in-aromatase-inhibitor-induced-musculoskeletal-symptoms-36737https://curecurrent.com/trials/nab-paclitaxel-abraxane-with-or-without-mifepristone-in-patients-with-advanced-breast-cancer-36738https://curecurrent.com/trials/vaccine-therapy-trastuzumab-and-vinorelbine-in-treating-patients-with-locally-recurrent-or-metastatic-breast-cancer-36739https://curecurrent.com/trials/cognition-in-the-study-of-tamoxifen-and-raloxifene-36740https://curecurrent.com/trials/carboplatin-gemcitabine-hydrochloride-and-mifepristone-in-treating-patients-with-advanced-breast-cancer-or-recurrent-or-36741https://curecurrent.com/trials/irinotecan-and-capecitabine-in-treating-patients-with-solid-tumors-36742https://curecurrent.com/trials/neoadjuvant-letrozole-plus-metformin-vs-letrozole-plus-placebo-for-er-positive-postmenopausal-breast-cancer-36743https://curecurrent.com/trials/weight-fluctuation-after-breast-cancer-treatment-36744https://curecurrent.com/trials/trial-of-inquiry-based-stress-reduction-ibsr-program-for-brca1-2-mutation-carriers-36745https://curecurrent.com/trials/lol-it-s-all-improv-after-cancer-the-impact-of-improvisational-comedy-on-well-being-among-patients-with-cancer-36746https://curecurrent.com/trials/evaluation-of-response-to-two-schedules-of-capecitabine-in-patients-with-metastatic-breast-cancer-36747https://curecurrent.com/trials/observational-study-to-evaluate-the-effectiveness-of-onlife-in-improving-cipn-in-patients-with-colon-or-breast-cancer-af-36748https://curecurrent.com/trials/tlr8-agonist-vtx-2337-and-cyclophosphamide-in-treating-patients-with-metastatic-persistent-recurrent-or-progressive-soli-36749https://curecurrent.com/trials/study-evaluating-the-combination-of-neratinib-and-capecitabine-in-solid-tumors-and-breast-cancer-36750https://curecurrent.com/trials/evaluation-of-a-novel-infra-red-breast-imaging-system-for-risk-assessment-in-women-at-high-risk-for-breast-cancer-36751https://curecurrent.com/trials/a-phase-ii-study-of-irinotecan-in-3-line-or-more-therapy-in-local-recurrence-or-metastatic-breast-cancer-36752https://curecurrent.com/trials/gw572016-combined-with-trastuzumab-for-the-treatment-of-previously-trastuzumab-treated-breast-cancer-36753https://curecurrent.com/trials/effects-of-diet-and-exercise-on-ductal-carcinoma-in-situ-36754https://curecurrent.com/trials/cisplatin-paclitaxel-and-everolimus-in-treating-patients-with-metastatic-breast-cancer-36755https://curecurrent.com/trials/patient-assisted-compression-impact-on-image-quality-and-workflow-36756https://curecurrent.com/trials/dietary-fat-eicosanoids-and-breast-cancer-risk-36757https://curecurrent.com/trials/analgesic-effects-of-ultrasound-guided-pec-blocks-on-analgesic-opioid-consumption-of-cancer-surgery-patients-36758https://curecurrent.com/trials/gw572016-in-patients-with-advanced-or-metastatic-breast-cancer-36759https://curecurrent.com/trials/the-attitudes-communication-treatment-and-support-intervention-to-reduce-breast-cancer-treatment-disparity-36760https://curecurrent.com/trials/effects-of-mediterranean-diet-and-naltrexone-bupropion-treatment-in-obese-breast-cancer-patients-36761https://curecurrent.com/trials/initial-oral-vinorelbine-dosing-schedules-in-clinical-routine-in-germany-and-austria-36762https://curecurrent.com/trials/mindfulness-breast-cancer-and-psycho-immune-dysregulation-36763https://curecurrent.com/trials/this-study-was-a-prospective-one-arm-open-phase-ii-clinical-trial-a-systematic-review-of-the-pcr-of-apatinib-in-combinat-36764https://curecurrent.com/trials/eribulin-versus-vinorelbine-in-subjects-with-locally-recurrent-or-metastatic-breast-cancer-previously-treated-with-anthr-36765https://curecurrent.com/trials/comparison-of-erector-spinae-plane-block-with-thoracic-paravertebral-block-for-breast-surgery-36766https://curecurrent.com/trials/pharmacokinetic-study-of-capecitabine-in-elderly-cancer-patient-75-years-36767https://curecurrent.com/trials/tilmanocept-vs-sulfur-colloid-in-sentinel-lymph-node-biopsy-36768https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-epoetin-beta-neorecormon-in-anemic-participants-with-breast-cancer-undergoing-36769https://curecurrent.com/trials/reliability-of-subcutaneous-echogenicity-seg-grade-and-subcutaneous-echo-free-space-sefs-grade-36770https://curecurrent.com/trials/effect-of-resistance-training-variable-manipulation-in-postmenopausal-breast-cancer-survivors-36771https://curecurrent.com/trials/effect-of-weight-on-the-population-pharmacokinetic-analysis-of-doxorubicin-and-cyclophosphamide-36772https://curecurrent.com/trials/adipose-tissue-transfer-for-moderate-breast-cancer-conservative-treatment-sequella-36773https://curecurrent.com/trials/targeted-intraoperative-therapy-registry-at-bethesda-north-hospital-targit-36774https://curecurrent.com/trials/blood-test-for-early-detection-of-breast-cancer-using-todos-medical-breast-1-tm-b1-assay-36775https://curecurrent.com/trials/a-clinical-trial-evaluating-the-safety-and-clinical-activity-of-radioiodide-131i-as-a-novel-targeted-therapy-for-metasta-36776https://curecurrent.com/trials/study-evaluating-neratinib-plus-paclitaxel-vs-trastuzumab-plus-paclitaxel-in-erbb-2-positive-advanced-breast-cancer-36777https://curecurrent.com/trials/strain-echocardiography-to-predict-cardiotoxicity-in-patients-receiving-chemotherapy-containing-doxorubicin-36778https://curecurrent.com/trials/adapted-physical-activity-effect-and-fatigue-in-patients-with-breast-cancer-36779https://curecurrent.com/trials/dendritic-cell-therapy-for-brain-metastases-from-breast-or-lung-cancer-36780https://curecurrent.com/trials/medico-economic-study-comparing-intrabeam-on-surgical-resection-bed-to-conventional-surgery-ebrt-in-breast-cancer-36781https://curecurrent.com/trials/epainq-feasibility-study-36782https://curecurrent.com/trials/a-study-of-mitoxantrone-hydrochloride-liposome-injection-in-advanced-recurrent-or-metastatic-breast-cancer-36783https://curecurrent.com/trials/synthetic-aperture-radar-detection-of-breast-tumours-36784https://curecurrent.com/trials/genetic-susceptibility-and-risk-of-second-cancers-in-patients-who-have-undergone-stem-cell-transplant-for-cancer-36785https://curecurrent.com/trials/a-study-to-examine-the-effects-of-an-experimental-drug-on-women-with-breast-cancer-and-metastatic-bone-disease-mbd-0822-36786https://curecurrent.com/trials/mcs110-combined-with-neoadjuvant-doxorubicin-cyclophosphamide-and-weekly-paclitaxel-in-patients-with-hormone-receptor-po-36787https://curecurrent.com/trials/pre-surgical-qigong-therapy-for-women-with-breast-cancer-36788https://curecurrent.com/trials/a-study-of-dalotuzumab-mk-0646-in-breast-cancer-patients-mk-0646-013-36789https://curecurrent.com/trials/comparative-effectiveness-feasibility-trial-for-insomnia-among-breast-cancer-survivors-36790https://curecurrent.com/trials/fulvestrant-and-palbociclib-with-or-without-copanlisib-in-treating-patients-with-hormone-receptor-positive-her2-negative-36791https://curecurrent.com/trials/a-study-of-a-combination-of-trastuzumab-and-capecitabine-with-or-without-pertuzumab-in-patients-with-her2-positive-metas-36792https://curecurrent.com/trials/before-decision-aid-implementation-study-36793https://curecurrent.com/trials/study-evaluating-hki-272-neratinib-in-subjects-with-advanced-breast-cancer-36794https://curecurrent.com/trials/evaluation-of-the-efficacy-of-hippocampal-avoidance-on-the-cognitive-toxicity-of-whole-brain-radiation-therapy-after-sur-36795https://curecurrent.com/trials/imaging-for-response-assessment-of-neoadjuvant-chemotherapy-in-primary-breast-cancer-galadon-36796https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-breast-cancer-that-is-metastatic-or-cannot-be-treated-with-surgery-36797https://curecurrent.com/trials/post-op-outcomes-of-enhanced-energy-delivery-dissection-for-mastectomy-with-immediate-breast-reconstruction-36798https://curecurrent.com/trials/impact-of-loft-therapy-on-breast-cancer-survivors-36799https://curecurrent.com/trials/anti-cancer-stem-cell-activity-of-pre-operative-bevacizumab-and-chemotherapy-in-breast-cancer-36800https://curecurrent.com/trials/bone-pain-score-validation-initiative-36801https://curecurrent.com/trials/effect-of-a-clinical-nutrition-intervention-program-in-breast-cancer-patients-during-antineoplastic-treatment-36802https://curecurrent.com/trials/patient-activated-controlled-expansion-pace-trial-36803https://curecurrent.com/trials/bone-marrow-or-peripheral-stem-cell-transplantation-in-treating-patients-with-breast-cancer-36804https://curecurrent.com/trials/s0300-celecoxib-in-preventing-breast-cancer-in-premenopausal-women-36805https://curecurrent.com/trials/study-evaluating-neratinib-hki-272-in-combination-with-vinorelbine-in-subjects-with-solid-tumors-and-metastatic-breast-c-36806https://curecurrent.com/trials/triple-negative-breast-cancer-identification-pilot-study-of-predictive-transcriptome-profiles-of-early-tumor-drug-resist-36807https://curecurrent.com/trials/trastuzumab-herceptin-bevacizumab-and-docetaxel-taxotere-trial-in-stage-iv-metastatic-breast-cancer-mbc-patients-36808https://curecurrent.com/trials/effect-of-omega-3-on-atrophic-vaginitis-in-breast-cancer-survivors-36809https://curecurrent.com/trials/study-evaluating-neratinib-versus-lapatinib-plus-capecitabine-for-erbb2-positive-advanced-breast-cancer-36810https://curecurrent.com/trials/measuring-the-effect-of-radiation-therapy-on-patient-activity-levels-36811https://curecurrent.com/trials/pazopanib-in-treating-patients-with-recurrent-or-metastatic-breast-cancer-36812https://curecurrent.com/trials/feasibility-study-of-breast-mri-in-decubitus-position-36813https://curecurrent.com/trials/5-years-follow-up-with-adjuvant-therapy-for-women-with-breast-invasive-carcinoma-36814https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-early-stage-breast-cancer-that-has-been-removed-by-surgery-36815https://curecurrent.com/trials/clinical-benefit-of-spa-care-on-severe-radiation-induced-fibrosis-after-postoperative-radiotherapy-for-breast-cancer-36816https://curecurrent.com/trials/metastatic-breast-carcinoma-and-women-sexual-quality-of-life-36817https://curecurrent.com/trials/rna-and-heat-shock-protein-biomarkers-in-radiation-induced-fibrosis-in-breast-cancer-36818https://curecurrent.com/trials/use-of-compressed-sensing-in-breast-mri-36819https://curecurrent.com/trials/effects-of-an-ict-platform-for-assessment-and-management-of-patient-reported-symptoms-during-treatment-for-breast-cancer-36820https://curecurrent.com/trials/interest-of-self-compression-technique-on-tolerance-of-mammography-36821https://curecurrent.com/trials/physical-activities-by-technology-help-path-36822https://curecurrent.com/trials/a-phase-ii-neo-adjuvant-study-assessing-tch-docetaxel-carboplatin-and-trastuzumab-and-tchl-docetaxel-carboplatin-trastuz-36823https://curecurrent.com/trials/pilot-study-evaluating-a-perioperative-e-follow-up-protocol-in-patients-with-ambulatory-surgery-for-breast-cancer-36824https://curecurrent.com/trials/weight-loss-pilot-study-in-postmenopausal-breast-cancer-survivors-36825https://curecurrent.com/trials/tkm-080301-for-primary-or-secondary-liver-cancer-36826https://curecurrent.com/trials/the-impact-of-spc-on-advanced-breast-cancer-patients-36827https://curecurrent.com/trials/accountability-for-cancer-care-through-undoing-racism-and-equity-36828https://curecurrent.com/trials/feasibility-of-blood-oxygenation-level-dependent-contrast-bold-breast-mri-induced-by-breath-holding-36829https://curecurrent.com/trials/rosuvastatin-in-treating-women-with-cardiovascular-complications-who-are-undergoing-chemotherapy-for-breast-cancer-36830https://curecurrent.com/trials/preoperative-window-of-endocrine-therapy-provides-information-to-increase-compliance-36831https://curecurrent.com/trials/immediate-or-delayed-naturopathic-medicine-in-combination-with-neo-adjuvant-chemotherapy-for-breast-cancer-36832https://curecurrent.com/trials/effectiveness-and-quality-of-life-analysis-of-palonosetron-against-ondansetron-combined-with-dexamethasone-and-fosaprepi-36833https://curecurrent.com/trials/docetaxel-and-ptk787-in-metastatic-breast-cancer-patients-and-gynecological-cancer-patients-36834https://curecurrent.com/trials/lapatinib-in-metastatic-breast-cancer-resistant-to-hormone-therapy-36835https://curecurrent.com/trials/immunotep-au-68-ga-imp-288-for-patients-with-a-recurrence-of-her2-negative-breast-carcinoma-expressing-cea-36836https://curecurrent.com/trials/xeloda-capecitabine-and-external-beam-radiation-36837https://curecurrent.com/trials/gsm-genitourinary-syndrome-of-menopause-management-in-breast-cancer-survivors-36838https://curecurrent.com/trials/exemestane-in-combination-with-fulvestrant-in-postmenopausal-women-with-hormone-sensitive-advanced-breast-cancer-36839https://curecurrent.com/trials/neo-adjuvant-therapy-with-anastrozole-plus-pazopanib-in-stage-ii-and-iii-er-breast-cancer-36840https://curecurrent.com/trials/a-study-of-the-addition-of-metronomic-capecitabine-to-standard-adjuvant-therapy-in-high-risk-her2-bc-patients-36841https://curecurrent.com/trials/a-phase-1-2-study-of-hki-272-neratinib-in-combination-with-paclitaxel-taxol-in-subjects-with-solid-tumors-and-breast-can-36842https://curecurrent.com/trials/tolerance-of-picc-line-versus-implanted-port-for-adjuvant-chemotherapy-in-early-breast-cancer-36843https://curecurrent.com/trials/the-impetus-cancer-trial-a-technology-delivered-physical-activity-intervention-in-cancer-36844https://curecurrent.com/trials/a-phase-1-2-study-of-hki-272-neratinib-in-combination-with-trastuzumab-herceptin-in-subjects-with-advanced-breast-cancer-36845https://curecurrent.com/trials/docetaxel-with-or-without-a-phytochemical-in-treating-patients-with-breast-cancer-36846https://curecurrent.com/trials/study-to-validate-a-model-of-surgical-deescalation-in-atypicals-breast-lesions-36847https://curecurrent.com/trials/phase-ii-nct-neoadjuvant-chemotherapy-w-weekly-abraxane-in-combination-with-carboplatin-bevacizumab-in-breast-cancer-36848https://curecurrent.com/trials/muc1-vaccine-for-triple-negative-breast-cancer-36849https://curecurrent.com/trials/influence-of-multidisciplinary-breast-tumor-board-on-physician-decision-36850https://curecurrent.com/trials/fulvestrant-in-metastatic-breast-cancer-36851https://curecurrent.com/trials/prospective-observational-study-of-febrile-neutropenia-fn-and-pegfilgrastim-primary-prophylaxis-in-breast-cancer-and-non-36852https://curecurrent.com/trials/mk2206-in-combination-with-anastrozole-fulvestrant-or-anastrozole-and-fulvestrant-in-treating-postmenopausal-women-with-36853https://curecurrent.com/trials/single-dose-ablative-radiation-treatment-for-early-stage-breast-cancer-36854https://curecurrent.com/trials/evaluation-of-the-nanthealth-gps-cancer-test-in-patients-with-advanced-cancers-36855https://curecurrent.com/trials/effects-of-granulocyte-colony-stimulating-factor-g-csf-trastuzumab-and-vinorelbine-on-immune-cell-function-36856https://curecurrent.com/trials/an-open-label-phase-ii-trial-of-continuous-low-irradiance-photodynamic-therapy-clipt-using-verteporfin-visudyne-for-the-36857https://curecurrent.com/trials/web-base-app-to-improve-aromatase-inhibitor-adherence-36858https://curecurrent.com/trials/radiomics-of-mp-mri-assessing-nac-outcome-in-breast-cancer-36859https://curecurrent.com/trials/investigation-on-the-efficacy-of-wo-2085-moisturising-cream-for-breast-cancer-patients-suffering-from-vulvovaginal-dryne-36860https://curecurrent.com/trials/women-s-knowledges-about-gynaecological-aftercare-36861https://curecurrent.com/trials/comparison-of-flexhd-and-alloderm-outcomes-in-breast-reconstructive-surgery-36862https://curecurrent.com/trials/advanced-breast-cancer-and-lifestyle-exercise-study-36863https://curecurrent.com/trials/glembatumumab-vedotin-nivolumab-and-ipilimumab-in-treating-patients-with-advanced-metastatic-solid-tumors-that-cannot-be-36864https://curecurrent.com/trials/prolonged-or-standard-infusion-of-cefepime-hydrochloride-in-treating-patients-with-febrile-neutropenia-36865https://curecurrent.com/trials/safety-and-efficacy-of-ypeg-rhg-csf-in-cancer-patients-receiving-chemotherapy-36866https://curecurrent.com/trials/study-of-the-effect-of-glutamine-supplementation-on-chemotherapy-induced-toxicities-in-breast-cancer-patients-36867https://curecurrent.com/trials/a-study-of-ly573636-sodium-in-patients-with-metastatic-breast-cancer-36868https://curecurrent.com/trials/cryoablation-for-invasive-breast-carcinoma-following-neoadjuvant-therapy-36869https://curecurrent.com/trials/analgesic-effect-to-postoperative-pain-after-mastectomy-ultrasound-guided-serratus-anterior-plane-block-36870https://curecurrent.com/trials/innovation-in-mammography-tomosynthesis-pathways-36871https://curecurrent.com/trials/combined-intra-articular-shoulder-injection-and-stellate-ganglion-block-in-chronic-post-mastectomy-shoulder-pain-36872https://curecurrent.com/trials/a-non-interventional-study-with-paclitaxel-onkovis-paclitaxel-utilized-for-the-treatment-of-cancer-36873https://curecurrent.com/trials/an-observational-study-in-patients-with-her2-positive-metastatic-breast-cancer-systhers-registry-36874https://curecurrent.com/trials/post-marketing-surveillance-study-of-eribulin-on-the-status-and-factors-for-the-development-of-peripheral-neuropathy-in-36875https://curecurrent.com/trials/rapid-randomized-trial-of-accelerated-partial-breast-irradiation-36876https://curecurrent.com/trials/tissue-procurement-protocol-for-patients-undergoing-treatment-for-early-stage-breast-cancer-36877https://curecurrent.com/trials/physical-activity-and-neuropsychological-outcomes-in-a-cancer-population-36878https://curecurrent.com/trials/genetic-testing-in-predicting-response-to-paclitaxel-in-women-with-breast-cancer-36879https://curecurrent.com/trials/maintenance-hormone-therapy-for-postmenopausal-hr-positive-advanced-breast-cancer-36880https://curecurrent.com/trials/study-of-pyrotinib-in-patients-with-human-epidermalgrowth-factor-receptor-2-her2-positive-advanced-breast-cancer-36881https://curecurrent.com/trials/study-evaluating-pyrotinib-in-combination-with-capecitabine-in-patients-with-her2-positive-metastatic-breast-cancer-36882https://curecurrent.com/trials/a-study-of-pyrotinib-plus-capecitabine-versus-lapatinib-plus-capecitabine-in-patients-with-her2-metastatic-breast-cancer-36883https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-nktr-102-in-patients-with-metastatic-or-locally-advanced-breast-cancer-36884https://curecurrent.com/trials/breast-mri-for-neaodjuvant-chemotherapy-response-prediction-and-evaluation-in-breast-cancer-36885https://curecurrent.com/trials/remifemin-preventing-the-climacteric-symptoms-in-breast-cancer-36886https://curecurrent.com/trials/the-plan-and-stand-study-reducing-sitting-time-in-breast-cancer-survivors-36887https://curecurrent.com/trials/stress-and-immunity-breast-cancer-project-36888https://curecurrent.com/trials/paclitaxel-carboplatin-and-panitumumab-in-treating-patients-with-metastatic-breast-cancer-36889https://curecurrent.com/trials/kerastat-skin-therapy-in-treating-radiation-dermatitis-in-patients-with-newly-diagnosed-stage-0-iiia-breast-cancer-36890https://curecurrent.com/trials/mirvetuximab-soravtansine-img853-in-folate-receptor-alpha-expressing-tnbc-36891https://curecurrent.com/trials/at13387-in-adults-with-refractory-solid-tumors-36892https://curecurrent.com/trials/stem-cell-transplant-with-th2-tc2-cells-to-treat-advanced-breast-cancer-36893https://curecurrent.com/trials/breast-cancer-rehabilitation-program-in-improving-quality-of-life-in-breast-cancer-survivors-36894https://curecurrent.com/trials/a-study-to-determine-the-activity-of-caelyx-with-trastuzumab-and-docetaxel-in-the-treatment-of-metastatic-breast-cancer-36895https://curecurrent.com/trials/evaluation-of-ocoxin-viusid-in-breast-cancer-36896https://curecurrent.com/trials/vascular-and-cognitive-assessments-in-patients-with-breast-cancer-undergoing-chemotherapy-after-surgery-36897https://curecurrent.com/trials/the-effect-of-yoga-on-barriers-to-occupational-engagement-in-african-american-breast-cancer-survivors-36898https://curecurrent.com/trials/women-s-experiences-of-mammography-quantitative-evaluation-36899https://curecurrent.com/trials/intraoperative-imagery-of-breast-cancer-with-folate-fitc-ec17-36900https://curecurrent.com/trials/measuring-stress-in-women-with-newly-diagnosed-stage-i-stage-ii-or-stage-iii-breast-cancer-or-ductal-carcinoma-in-situ-o-36901https://curecurrent.com/trials/changing-health-behaviors-to-manage-chronic-conditions-in-community-dwelling-african-american-breast-cancer-survivors-36902https://curecurrent.com/trials/interactive-gentle-yoga-in-improving-quality-of-life-in-patients-with-stage-i-iii-breast-cancer-undergoing-radiation-the-36903https://curecurrent.com/trials/role-of-hyaluronic-acid-in-causing-cancer-stem-cell-growth-in-the-bones-of-patients-with-breast-cancer-36904https://curecurrent.com/trials/study-of-pembrolizumab-plus-chemotherapy-in-patients-with-advanced-cancer-pembroplus-36905https://curecurrent.com/trials/safety-and-efficacy-of-pegteograstim-in-korean-breast-cancer-patients-36906https://curecurrent.com/trials/proton-therapy-for-lymph-nodes-in-breast-cancer-36907https://curecurrent.com/trials/a-mail-and-video-based-weight-loss-trial-in-breast-cancer-survivors-36908https://curecurrent.com/trials/national-breast-cancer-and-lymphedema-registry-36909https://curecurrent.com/trials/veliparib-in-treating-patients-with-malignant-solid-tumors-that-do-not-respond-to-previous-therapy-36910https://curecurrent.com/trials/lymphatic-function-in-patients-who-have-undergone-breast-cancer-treatment-36911https://curecurrent.com/trials/symptom-management-after-breast-cancer-surgery-36912https://curecurrent.com/trials/mint-i-multi-institutional-neo-adjuvant-therapy-mammaprint-project-i-36913https://curecurrent.com/trials/measuring-the-impact-of-mammaprint-on-adjuvant-and-neoadjuvant-treatment-in-breast-cancer-patients-a-prospective-registr-36914https://curecurrent.com/trials/intravenous-ascorbic-acid-supplementation-in-neoadjuvant-chemotherapy-for-breast-cancer-36915https://curecurrent.com/trials/trial-of-pregabalin-for-granulocyte-colony-stimulating-factor-gcsf-induced-bone-pain-36916https://curecurrent.com/trials/impact-of-5-fraction-stereotactic-partial-breast-irradiation-and-whole-breast-irradiation-on-cosmetic-outcome-and-patien-36917https://curecurrent.com/trials/phase-ii-study-of-ixabepilone-in-metastatic-breast-cancer-and-its-effects-on-the-ultrastructure-of-neurons-36918https://curecurrent.com/trials/prophylactic-gabapentin-for-taxane-induced-arthralgia-and-myalgia-syndrome-in-breast-cancer-patients-undergoing-adjuvant-36919https://curecurrent.com/trials/immune-effects-in-patients-treated-with-whole-breast-irradiation-36920https://curecurrent.com/trials/effects-of-herbal-products-on-reduction-of-radiation-induced-dermatitis-in-breast-cancer-patients-36921https://curecurrent.com/trials/a-prospective-observational-study-about-adjuvant-or-neoadjuvant-chemotherapy-related-adverse-effects-in-postmenopausal-b-36922https://curecurrent.com/trials/non-interventional-study-with-nab-paclitaxel-abraxane-36923https://curecurrent.com/trials/the-lightpath-breast-cancer-study-36924https://curecurrent.com/trials/study-of-biomarker-profiles-in-asia-pacific-erb2-her2-breast-cancer-patients-treated-with-lapatinib-36925https://curecurrent.com/trials/pilot-study-of-patient-s-adherence-to-tykerb-tyverb-capecitabine-in-metastatic-breast-cancer-36926https://curecurrent.com/trials/evaluation-of-a-three-dimensional-functional-metabolic-imaging-and-risk-assessment-system-in-classifying-women-for-likel-36927https://curecurrent.com/trials/evaluation-of-real-imaging-s-3d-functional-metabolic-imaging-and-risk-assessment-mira-system-36928https://curecurrent.com/trials/irinotecan-for-advanced-and-metastatic-breast-cancer-36929https://curecurrent.com/trials/comparison-of-contrast-enhanced-mammography-to-breast-mri-in-screening-patients-at-increased-risk-for-breast-cancer-36930https://curecurrent.com/trials/evaluation-of-a-3d-functional-metabolic-imaging-and-risk-assessment-system-in-classifying-women-for-likelihood-of-breast-36931https://curecurrent.com/trials/a-biomarker-study-of-palbociclib-fulvestrant-for-second-and-third-line-of-postmenopausal-women-with-hr-her2-advanced-bre-36932https://curecurrent.com/trials/trial-of-eribulin-in-patients-who-do-not-achieve-pathologic-complete-response-pcr-following-neoadjuvant-chemotherapy-36933https://curecurrent.com/trials/breast-cancer-long-term-outcome-of-cardiac-dysfunction-36934https://curecurrent.com/trials/ganetespib-paclitaxel-trastuzumab-and-pertuzumab-for-metastatic-human-epidermal-growth-factor-receptor-2-positive-breast-36935https://curecurrent.com/trials/cixutumumab-and-temsirolimus-in-treating-patients-with-locally-recurrent-or-metastatic-breast-cancer-36936https://curecurrent.com/trials/a-dose-finding-study-of-pertuzumab-perjeta-in-combination-with-trastuzumab-herceptin-in-healthy-male-participants-and-wo-36937https://curecurrent.com/trials/assessment-of-ovarian-reserve-in-female-cancer-survivors-36938https://curecurrent.com/trials/tracking-physical-activity-throughout-chemotherapy-for-breast-cancer-36939https://curecurrent.com/trials/application-of-surgical-navigation-system-in-sentinel-lymph-node-of-breast-cancer-research-36940https://curecurrent.com/trials/project-move-increasing-physical-activity-among-breast-cancer-survivors-36941https://curecurrent.com/trials/impact-of-body-weight-on-pharmacokinetic-analysis-of-doxorubicin-cyclophosphamide-in-breast-cancer-36942https://curecurrent.com/trials/randomized-placebo-controlled-trial-of-glutamine-for-breast-cancer-patients-with-peripheral-neuropathy-36943https://curecurrent.com/trials/partial-breast-irradiation-pbi-for-selected-patients-with-early-breast-cancer-36944https://curecurrent.com/trials/exercise-and-metformin-in-colorectal-and-breast-cancer-survivors-36945https://curecurrent.com/trials/the-impact-of-a-physical-activity-program-on-biomarkers-of-aging-during-chemotherapy-for-breast-cancer-36946https://curecurrent.com/trials/a-study-for-safety-and-effectiveness-of-imc-a12-by-itself-or-combined-with-antiestrogens-to-treat-breast-cancer-36947https://curecurrent.com/trials/99mtc-labelled-affibody-spect-ct-imaging-for-breast-cancer-her2-characterization-36948https://curecurrent.com/trials/phase-i-dose-escalation-study-of-bay94-9343-given-by-intravenous-infusion-every-3-weeks-in-japanese-subjects-with-advanc-36949https://curecurrent.com/trials/radiofrequency-ablation-in-breast-cancer-36950https://curecurrent.com/trials/alisertib-mln8237-in-participants-with-ovarian-fallopian-tube-or-peritoneal-cancer-preceded-by-phase-1-study-of-mln8237-36951https://curecurrent.com/trials/mri-in-ductal-carcinoma-in-situ-dcis-36952https://curecurrent.com/trials/a-prospective-observational-study-about-adjuvant-or-neoadjuvant-chemotherapy-related-adverse-effects-in-premenopausal-br-36953https://curecurrent.com/trials/triple-negative-breast-cancer-a-new-perspective-on-biomarkers-36954https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-with-high-intensity-focused-ultrasound-hifu-36955https://curecurrent.com/trials/study-of-fulvestrant-everolimus-in-post-menopausal-hormone-receptor-metastatic-breast-ca-resistant-to-ai-36956https://curecurrent.com/trials/early-rehabilitation-after-immediate-reconstruction-with-tei-in-breast-cancer-patients-36957https://curecurrent.com/trials/internal-mammary-sentinel-lymph-node-biopsy-with-modified-injection-technique-36958https://curecurrent.com/trials/psychosexual-intervention-in-patients-with-stage-i-iii-gynecologic-or-breast-cancer-36959https://curecurrent.com/trials/eniluracil-hand-foot-syndrome-36960https://curecurrent.com/trials/ventilation-efficacy-of-size-3-or-size-4-i-gel-in-female-patient-weighing-50-to-60-kilograms-36961https://curecurrent.com/trials/feasibility-study-assessing-the-treatment-of-fibroadenomata-with-a-circumferential-sonication-treatment-with-hifu-36962https://curecurrent.com/trials/metabolizing-enzyme-genotype-versus-exemestane-metabolism-profiles-36963https://curecurrent.com/trials/sensory-recovery-of-reconstructed-breast-with-breast-reconstructive-options-36964https://curecurrent.com/trials/database-of-data-collection-36965https://curecurrent.com/trials/gated-radiotherapy-in-left-sided-breast-cancer-patients-36966https://curecurrent.com/trials/a-self-management-energy-conservation-program-for-cancer-related-fatigue-36967https://curecurrent.com/trials/carboplatin-with-or-without-zd4054-in-patients-with-metastatic-breast-cancer-36968https://curecurrent.com/trials/ex-vivo-performance-evaluation-of-the-histolog-scanner-for-human-breast-carcinoma-detection-on-fresh-breast-core-biopsie-36969https://curecurrent.com/trials/individual-patient-expanded-access-glembatumumab-vedotin-36970https://curecurrent.com/trials/a-study-of-neoadjuvant-letrozole-taselisib-versus-letrozole-placebo-in-post-menopausal-women-with-breast-cancer-lorelei-36971https://curecurrent.com/trials/the-multi-center-validation-study-of-internal-mammary-lymph-biopsy-with-modified-injection-technique-in-breast-cancer-pa-36972https://curecurrent.com/trials/cell-free-dna-and-its-integrity-using-alu-sequences-as-a-biomarker-for-diagnosis-of-breast-cancer-36973https://curecurrent.com/trials/safety-and-tolerability-of-msi-1436c-in-metastatic-breast-cancer-36974https://curecurrent.com/trials/phase-ii-pilot-study-assessing-efficacy-of-a-cisplatin-metronomic-cyclophosphamide-treatment-in-patients-with-metastatic-36975https://curecurrent.com/trials/study-of-ont-10-and-varlilumab-to-treat-advanced-ovarian-or-breast-cancer-36976https://curecurrent.com/trials/chemotherapy-and-peripheral-stem-cell-transplantation-followed-by-trastuzumab-in-treating-women-with-metastatic-breast-c-36977https://curecurrent.com/trials/improving-breast-cancer-diagnostic-by-novel-sonographictechniques-study-36978https://curecurrent.com/trials/cystic-breast-masses-by-contrast-enhanced-ultrasound-ceus-36979https://curecurrent.com/trials/flt-pet-in-measuring-treatment-response-in-patients-with-newly-diagnosed-estrogen-receptor-positive-her2-negative-stage-36980https://curecurrent.com/trials/laser-ingaalp-660nm-to-prevent-radiodermatitis-in-breast-cancer-patients-submitted-to-radiation-therapy-36981https://curecurrent.com/trials/12-week-exercise-intervention-program-versus-observation-in-early-stage-breast-cancer-patients-on-the-impact-on-mental-h-36982https://curecurrent.com/trials/simulated-altitude-to-optimize-aerobic-exercise-among-breast-cancer-survivors-with-limited-mobility-36983https://curecurrent.com/trials/feasibility-of-activity-monitoring-in-patients-with-cancer-physical-activity-monitoring-in-cancer-patients-pamcap-36984https://curecurrent.com/trials/bootcamp-during-neoadjuvant-chemotherapy-for-breast-cancer-36985https://curecurrent.com/trials/preoperative-localisation-of-the-sentinel-lymph-node-in-breast-cancer-36986https://curecurrent.com/trials/feasibility-study-of-genomic-profiling-methods-and-timing-in-tumor-samples-36987https://curecurrent.com/trials/omitting-completion-axillary-treatment-in-sentinel-node-positive-breast-cancer-patients-undergoing-a-mastectomy-36988https://curecurrent.com/trials/digital-breast-tomosynthesis-in-younger-symptomatic-women-36989https://curecurrent.com/trials/brostallicin-and-cisplatin-in-treating-patients-with-metastatic-breast-cancer-36990https://curecurrent.com/trials/pixantrone-dimaleate-in-treating-patients-with-her2-negative-metastatic-breast-cancer-36991https://curecurrent.com/trials/akt-inhibitor-mk-2206-and-anastrozole-with-or-without-goserelin-acetate-in-treating-patients-with-stage-ii-iii-breast-ca-36992https://curecurrent.com/trials/fulvestrant-and-bevacizumab-in-treating-patients-with-metastatic-breast-cancer-36993https://curecurrent.com/trials/a-phase-1-study-of-single-agent-veliparib-in-japanese-subjects-with-advanced-solid-tumors-36994https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-with-high-intensity-focused-ultrasound-36995https://curecurrent.com/trials/management-of-women-with-brca1-2-mutation-36996https://curecurrent.com/trials/effect-of-health-education-on-female-teachers-knowledge-and-practices-regarding-early-breast-cancer-detection-and-screen-36997https://curecurrent.com/trials/oral-vt-464-in-patients-with-castration-resistant-prostate-cancer-previously-treated-with-enzalutamide-androgen-receptor-36998https://curecurrent.com/trials/developing-mouse-models-of-breast-cancer-using-tissue-samples-from-women-with-breast-cancer-36999https://curecurrent.com/trials/musicotherapy-in-the-reduction-of-fatigue-in-women-with-breast-or-gynecological-cancer-under-radiotherapy-37000